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ABSTRACT
Extensive research indicates that false-positive mammograms (FPM) have been
associated with negative psychosocial and cancer-related beliefs, but only a handful of
studies examine Black women’s reactions to this experience. Additionally, these studies
do not investigate how organizational and provider-level factors in concert with
individual patient characteristics shape Black women’s experiences and reactions to FPM
results. The purpose of this study was to determine the impact of organizational, provider,
and individual-level factors on the processes and outcomes associated with FPM results
in Black women. This study had two specific aims:
1) To describe, using a mixed methods approach, the organizational and providerlevel characteristics of mammography facilities and their impact on Black women’s FPM
experiences and outcomes.
2) To determine, through quantitative methods, the relationship between receiving
a FPM result and future mammography intention among Black women.
Two phases of data collection were conducted as part of this study. Phase I began
in March 2016 and concluded October 2016. Observations, key informant interviews,
provider surveys, and analyses of screening and diagnostic data were used to describe the
facility and provider-level characteristics of five mammography screening centers in the
Columbia, South Carolina Metropolitan Statistical Area (MSA). Organizational and
provider data collected during Phase I were linked to patient survey data collected during
Phase II. The patient survey tool contained items that assessed demographic
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characteristics, breast cancer (BrCa) screening history, emotional states, coping
behaviors, cancer-related beliefs and attitudes in Black women with FPM and normal
results. Black women aged 40+, breast cancer free, who completed screening
mammograms from January to August 2016 at one of the previously mentioned screening
centers were eligible to participate. Women who received a FPM result were selected as
cases, matched controls were selected from women screened on the same day and site but
had normal mammograms. Patient surveys were administered from July 2016 to January
2017. Of the 132 patient surveys returned, 117 met the criteria for study inclusion.
No facility, provider, or patient factors were associated with two types of
satisfaction: general and provider interpersonal style. FPM status was one of several
patient characteristics associated with lower levels of satisfaction with convenience and
provider information communication. Facility and provider-level factors had negative and
positive effects on satisfaction with provider competence. Satisfaction with the clinical
environment was also influenced by facility characteristics. FPM status was only
associated with a higher perception of barriers to mammography, and perceived barriers
were associated with a lower intention to complete mammography. Afrocentric coping
behaviors moderated the perception of mammography barriers for women with FPM
results, weakening this relationship.
A variety of organizational, provider, and individual-level patient factors were
found to influence the processes and outcomes associated with FPM among Black
women. Receipt of FPM results appear to have a detrimental effect on mammography
satisfaction and intention in in Black women, but culturally-relevant behaviors such as
collective coping strategies may reduce the negative effects of FPM status. Study results
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reinforce the need for incorporating culturally-appropriate theoretical influences and the
operationalization of those influences to understand the contributions to racial inequities
in BrCa burden.
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CHAPTER 1
INTRODUCTION
1.1. Breast Cancer Burden
Despite steady declines in overall cancer mortality during the past three decades,
cancer remains the second leading cause of death in the United States.1 The burden of
cancer varies by gender as a result of sex-specific cancers such as BrCa. BrCa is the most
commonly diagnosed cancer in American women and the second leading cause of cancer
deaths in this population.1 In 2015, it is estimated that 40,290 American women died of
BrCa.2 BrCa mortality rates have increased by 0.4% per year in the United States until
1989, when BrCa mortality began a steady decline which continues to this day.2
Advances in the science and adoption of breast conservation surgery, adjuvant
chemotherapy, and tumor detection resulted in a 36% decrease in overall BrCa death
rates between 1989 and 2012.2,3 Due to the enduring presence of racial disparities through
the breast cancer continuum, BrCa mortality has decreased at a much slower rate among
Black women.
1.2 Racial Disparities in Breast Cancer Burden
Current BrCa mortality rates are 30.0 and 21.2 per 100,000, among Black and
White women, respectively.1 This disparity represents a 42% higher BrCa death rate in
Black women and is due to slower declines in BrCa mortality (-1.8% in Whites vs. -1.4%
in Blacks).1 Black-White inequities in BrCa death rates are driven by a plethora
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of interconnected biological, economic, social, cultural, and health system factors.2,4–7
Racial differences in BrCa incidence trends, disease progression, and treatment
are the primary drivers of Black women’s increased BrCa mortality.8–10 Between 1992
and 2012, BrCa incidence rose by 0.4% annually for Black women while remaining
constant in White women.2 In contrast to the historically higher BrCa incidence rates for
White women 50 years of age or older, Black and White women in this age group now
have similar rates (125.1 and 128.3 per 100,000 women, respectively).1 These trends in
combination with the fact that Black women are more likely to be diagnosed with larger
and advanced staged tumors have negative implications for treatment success and
subsequent mortality in this population.11–13
BrCa treatment-related disparities encompass issues related to Black women’s
access to appropriate therapies and treatment delays.8,14–16 Treatment delay consists of
two components: delays in initiating treatment post receiving a diagnosis of BrCa and
delays in completing diagnostic testing after symptom detection or notification of an
abnormal screening test (diagnostic delays).17,18 Diagnostic delay has emerged as a
significant behavioral factor explaining poor BrCa prognosis in Black women through its
contribution to advanced tumor stage at diagnosis and the influence on the timeliness of
the start of treatment.15,16,19–21 Black women are less likely to complete diagnostic testing
within the desired 60-day window than their White counterparts.16–18,20,22,23 Much
research has been devoted to understanding the causes and mechanisms responsible for
this behavioral trend, but no one factor explains this phenomenon.
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1.3 Contributions to BrCa Diagnostic Delay in Black Women
Of the many determinants of diagnostic delay among Black women, individuallevel factors have received the most attention.24,25 Sociodemographic characteristics that
impact healthcare access including: income, health insurance, and employment status,
have been most frequently cited as leading to diagnostic delay.16,20,24,25 Lack of
knowledge regarding BrCa screening, attitudes such as fear, and cancer-related beliefs
like cancer fatalism, have also been thought to affect Black women’s motivation to
complete follow-up testing.20,24,25 Clinical aspects of the BrCa screening population
include: non-adherence to mammography screening guidelines and self-detection of
tumors as opposed to mammography are also associated with diagnostic delays.16,19,26–28
1.4 Previous Mammography Screening Experiences and Diagnostic Delay
Prior research on the characteristics associated with follow-up delay in Black
women has paid little attention to Black women’s previous screening experiences and
their potential to influence the completion of diagnostic testing. Outside of studies of
racial discrimination and mistrust in the clinical encounter, virtually no efforts have
quantitatively linked past mammography experiences to Black women’s attitudes towards
diagnostic testing.29–33 Black women’s history of FPM results may be an importan,t but
understudied aspect of their screening experience.
One qualitative study of Black BrCa survivors presented accounts of women who
delayed seeking care for lumps due to past FPM results.34 Another study by Kerner et al.
examined multilevel influences on follow-up delays among Black women. Kerner et al.
found that Black women with previous FPMs were 60% more likely to have diagnostic
delays than Black women without a history of FPMs.35 Additionally, study participants
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with higher levels of cancer anxiety were less likely to complete their diagnostic followup within the recommended 90-day window.35 Both studies indicate a possible
connection between prior FPM results and mammography delay in Black women.
1.5 False-Positive Mammography Results
A FPM result is defined in health research literature as a screening mammogram
that requires additional follow-up testing, but does not lead to a cancer diagnosis.36–38
Clinically, FPMs correspond to a Breast Imaging-Reporting and Data System (BI-RADS)
classification of 0 (i.e., additional imaging evaluation and/or comparison to prior
mammograms in needed), 3 (i.e., probably benign finding), 4 (i.e., suspicious
abnormality) or 5 (i.e., highly suggestive of malignancy) that is confirmed as nonmalignant through one or more of the following procedures: diagnostic mammogram,
ultrasound, breast MRI, or biopsy.39 Normal mammograms are classified as BI-RADS 1
or 2.40
Anywhere from 5-10% of mammograms each year result in a FPM, but
cumulatively a woman has a 20-65% chance of receiving a FPM result depending on the
age at which she initiates screening (40 or 50 years old), her screening schedule (annual
vs. biennial), and her risk for FPM.41–44 Younger women (age 40-49), women with
heterogeneously dense breasts, those with a family history of BrCa, and previous FPM
results are at increased risk of receiving a FPM result.45 FPM rates are generally the same
for Black and White women, but facility and provider characteristics have been
documented to affect the prevalence of FPM in various racial groups.45–48 National data
indicate the that rates of abnormal mammography results have risen in recent decades.49
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Recommended mammography screening intervals have been lengthened in part due to
potential harms to women as a result of FPM.50–52
1.6 Impact of FPM Among Black Women
FPM results may lead to potentially negative patient-level outcomes, such as
additional financial costs due to follow-up testing, impaired daily function, negative
emotional states, and reduced levels of future BrCa screening intention and behavior.37,38
What, if any, effects FPM results may have on Black women’s satisfaction with their
mammography experiences, BrCa related beliefs and attitudes, and/or future screening
and follow-up behaviors is largely unknown due to the lack of research on FPM in this
population.
Black women in the United States inhabit different social, environmental,
economic, and cultural contexts than White women. As such these contexts impact Black
women’s BrCa risk and knowledge.53–56 Black women’s access to cancer screening
services is impacted by the quality of facilities and providers through residential
segregation.48,57,58 Extensive literature exists to describe the communication challenges
Black women face while navigating the healthcare system.59–62 The actions Black women
employ in the face of these challenges are shaped by cultural and social norms for
behavior within and outside the Black community. Thus, their experiences and outcomes
cannot be fully represented by research consisting of predominately White participants.63
Being that “Black women are not White women plus color, or Black men, plus gender”64,
research studies centered on Black women’s experiences and grounded in relevant
cultural frameworks are essential to explain and address racial inequities in BrCa
burden.65
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1.7 Specific Aims
The purpose of this study was to determine the impact of organizational, provider,
and individual-level factors on the processes and outcomes associated with FPM results
in Black women. The study was conducted in two phases and had two specific aims:
Specific Aim 1: To describe, using a mixed methods approach, the organizational
and provider-level characteristics of mammography facilities and their impact on Black
women’s FPM experiences and outcomes.
Research Question 1.1. What organizational, provider, and patient-level
characteristics predict high levels of satisfaction with their clinical encounter among
Black women experiencing a FPM result?
Specific Aim 2: To determine, through quantitative methods, the relationship
between receiving a FPM result and future mammography intention among Black
women.
Research Question 2.1. What is the relationship between receiving a FPM result
and BrCa behavioral beliefs (perceived benefits of mammography, perceived BrCa
susceptibility, and perceived barriers to mammography screening) among Black women?
Research Question 2.1.a. Do Black women’s emotional states explain the
relationship between a FPM result and BrCa behavioral beliefs (perceived benefits of
mammography, perceived BrCa susceptibility, and perceived barriers to mammography
screening)?
Research Question 2.1.b. Does the relationship between receipt of FPM results
and BrCa behavioral beliefs (perceived benefits of mammography, perceived BrCa
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susceptibility, and perceived barriers to mammography screening) vary by the coping
strategy employed?
Research Question 2.2. What is the relationship between BrCa behavioral beliefs
(perceived benefits of mammography, perceived BrCa susceptibility, and perceived
barriers to mammography screening) and the intention to complete future mammography
screening?
The next chapter will provide background information on the burden of BrCa
among Black women and the role of mammography and follow-up testing in South
Carolina. A review of the research to date on the prevalence, influences, and outcomes
associated with FPM results will also be presented.
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CHAPTER 2.
BACKGROUND AND SIGNIFICANCE
This chapter provides background on recent epidemiological and behavioral
trends as they relate to BrCa burden among Black women and potential influences on
these trends.
2.1 Cancer in Black Women
Cancer is the second leading cause of death among American women.66 It is
estimated that BrCa was responsible for 19% of cancer deaths in 2016, making it the
second leading cause of cancer deaths among Black women in that year.67 BrCa is also
the most prevalent cancer among Black women as it represents an estimated 32% of
cancer incidence for this group in 2016.67
2.2 Epidemiology of Breast Cancer in Black Women
2.2.1

Racial trends in breast cancer burden in the United States
In the United States, Black women have disproportionately higher BrCa mortality

rates than any other racial and ethnic group.2 This trend began in the late 1990’s due to a
slower decline in Black women’s BrCa mortality relative to White women (-1.4% and 1.8% percent annual change, respectively).67 Between 2010 and 2014, BrCa mortality
rates were 30.0 per 100,000 in Black women and 21.1 per 100,000 among White women
which represents a 42% higher death rate for Black women.1
In contrast, BrCa incidence has increased by 0.4% annually among Black women
between 2008 to 2012, while remaining stable for White women.2,68 Historically,
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BrCa incidence rates were highest in Black women under the age of 40, but higher among
White women over the age of 50.69,70 Recently, BrCa incidence in Black and White
women over the age of 50 has converged.2,7,71 Current five-year incidence rates (20092013) are essentially the same for Black and White women (125.1 and 128.3 per 100,000,
respectively). Higher BrCa incidence among Black women over 50 has the potential to
increase BrCa mortality, thus widening the current racial disparity in BrCa burden. This
trend is especially notable in the Southern US, with South Carolina serving as a typical
example.7
2.2.2

Racial Trends in Breast Cancer Burden in South Carolina
South Carolina contains 46 counties which are organized into four regions by the

South Carolina Department of Health and Environmental Control (See Figure 2.1). The
Columbia, SC MSA includes Richland, Lexington, Saluda, Fairfield, Kershaw, and
Calhoun counties and is largely located within South Carolina Department of Health and
Environmental Control’s Midlands region (See Figure 2.2). The most recent five-year
average (2009-2013) of BrCa incidence in the Columbia SC MSA was 132.0 per 100,000
which is above the Midlands region average of 127.8 per 100,000 or the state average of
127.2 per 100,000.72 BrCa mortality in the Columbia, SC MSA (23.7 per 100,000) was
similar to the regional and statewide mortality rates (22.8 and 22.4 per 100,000) during
that time period.72
In addition to increased BrCa burden, the Columbia, SC MSA displays significant
racial inequities in BrCa burden. This disparity has increased since the racial convergence
in national BrCa incidence rates. Average BrCa incidence and mortality rates by race and
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Figure 2.1 Map of South Carolina Department of Health and Environmental Control Regions and Central Offices
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Figure 2.2 Map of Columbia, SC Metropolitan Statistical Area

geographic location for 2012 and 2013 are presented in Table. 2.1. Black women in the
Columbia, SC MSA had higher rates of BrCa incidence (139.5 and 130.0 per 100,000)
and mortality (31.8 and 20.3 per 100,000) compared to White women.72 The Columbia,
SC MSA will require special attention to ensure that BrCa inequities do not widen.
Table 2.1 2012-2013 Breast Cancer Incidence and Mortality by Race and
Location72–74
Location
Incidence (Per 100,000)
Mortality (Per 100,000)
White

Black

White

Black

Columbia MSA

130.0

139.5

20.3

31.8

DHEC Midlands

125.2

134.6

20.3

29.4

South Carolina

128.2

127.9

19.3

28.5

United States

124.3

122.1

20.5

28.8

2.3 Contributions to Increased Breast Cancer Burden Among Black Women
Differences in BrCa risk factors; comorbid conditions, and tumor characteristics
at/prior to diagnosis; as well as the quality, effectiveness, and adoption of treatment
modalities are responsible for the elevated BrCa death rates among Black women.6,67 Prediagnostic differences in BrCa burden among Black women may lead to future increases
in BrCa mortality in this group. Mixed evidence suggests that reproductive factors such
as age at menarche and age at first pregnancy may increase the risk of different BrCa
subtypes in Black women based on age and/or menopausal status.75–77 Obesity and
diabetes also increase BrCa risk and are suspected to be driving forces responsible for
increasing BrCa incidence among Black women.2,68

12

Upon diagnosis, differences in disease severity also drive increased BrCa
mortality experienced by Black women.9,15,19,78–81 Black women are more likely to be
diagnosed with stage II, III and IV tumors compared to White women.15,19,78,82 After
controlling for socioeconomic and biological factors, delays in breast cancer diagnosis
and treatment have been documented as significant contributors to advanced staged
breast cancer in Black women.10,15,16,27,80,83–85
2.4 Racial Inequities in Breast Cancer Screening
Recent data from the 2015 National Health Interview Survey indicated that Black
women complete screening mammograms at somewhat higher rates than White women
(69.7% and 65.8%, respectively).66 Behavioral Risk Factors Surveillance System data
from 2014 reports similar screening trends in South Carolina with 81.4% of Black
women reporting use of screening mammography compared to 74.4% of White women.86
Despite higher initial screening rates, Black women are less likely to complete follow-up
screening tests if their initial mammogram reveals an abnormality.15,16,27,83,85
2.5 Addressing Mammography Follow-Up Among Black Women
Delayed mammography follow-up in Black women has been attributed to lower
levels of BrCa knowledge, BrCa related attitudes and beliefs, socioeconomic factors, and
issues related to healthcare access.24,87,88 Recommended client-oriented approaches for
increasing BrCa screening include: small media, group and one-on-one education
programs, such as Black Corals and the Witness Project, which address racial differences
in BrCa knowledge and beliefs, and system level interventions like the National Breast
and Cervical Cancer Early Detection Program, and patient navigation focus on removing
structural barriers.89–94 All of the previously mentioned programs and strategies have
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been implemented in South Carolina and have had positive impacts on BrCa screening
among Black women in the state.
2.5.1

Evidence-based Strategies to Improve Mammography Follow-Up Among
Black Women
The Black Corals program was developed by the St. James-Santee Family Health

Center in collaboration with the South Carolina Department of Health and Environmental
Control in 2008.95,96 Community-based group education sessions provided education
about BrCa risk factors, symptoms, detection and screening resources.95,96 Together with
a media campaign, client and provider reminders, the program lead to increased screening
rates and a reduction in the rates of missed appointments.95,96
Around the same time, a statewide lay education program was developed by the
National Cancer Institute-funded Community Network Program Center in South
Carolina, the South Carolina Cancer Disparities Community Network-II (SCCDCNII).97–99 The SCCDCN-II was a partnership between academic researchers and members
of a statewide Black faith organization.100 Together, members of the SCCDCN-II
implemented the South Carolina Witness Project, an evidenced-based group education
program that is culturally tailored to provide BrCa education to Black women.101,102
Women in the program demonstrated increased BrCa knowledge, decreased cancer
fatalism, and increased screening intentions after participating in the community
education sessions.103
The National Breast and Cervical Cancer Early Detection Program (NBCCEDP)
is one of the largest programs focused on addressing known barriers to mammography
follow-up with special attention to racial and ethnic minorities such Black women.91,104

14

The NBCCEDP consists of several activities such as the building of an infrastructure to
support the delivery of and reimbursement for BrCa screening and diagnostic services,
the provision of education and outreach services to support the recruitment of eligible
women, and the delivery of case management services and patient navigation to support
women as if they receive abnormal results.91,104 In South Carolina, the NBCCEDP funds
the Best Chance Network (BCN) which is administered by DHEC’s Division of Cancer
Prevention and Control.91,105 Since 1991, BCN has provided BrCa and cervical cancer
screening services to South Carolina residents aged 40-64 with incomes at or below
200% of the federal poverty level.91,105
The NBCCEDP has made significant progress in providing BrCa screening and
diagnostic procedures to low income women and women of color, but the program’s
efforts alone are not enough to reduce the BrCa burden in Black women. A comparison
of BrCa burden among NBCCEDP and non-NBCCEDP participants indicate that Black
participants were more likely to have late staged disease compared to Black women who
did not participate in the program.106 Across all groups of program participants, Black
women and women residing in the South were also more likely to present with late staged
disease.106 While the NBCCEDP has reduced participants’ time from initial screening to
diagnosis (diagnostic interval) between 1996 to 2005, Black women and other women of
color continue to have longer diagnostic intervals than White women.92
Patient navigation is another strategy that has been used address disparities in
BrCa screening and diagnostic follow up.93,94 As described by Dr. Harold Freeman, who
developed this model to address cancer disparities in Harlem in the 1980s, patient
navigators are lay persons from the same cultural and/or local communities as the patient
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population they serve.93,107 These lay persons are trained to assist patients in “navigating”
the healthcare system and overcoming the various cultural, social, systemic, and logistical
barriers that prevent patients from getting the recommended cancer care.93,107
The NBCCEDP is one of many programs which incorporates the use of patient
navigation to improve cancer care among Black women.104,108 While patient navigation
has been effective in reducing delays in the resolution of abnormal screening results;
Black participants continue to display longer diagnostic follow-up intervals compared to
their White counterparts even after controlling for factors such as the number of barriers
to diagnostic resolution or health insurance type.17,109–111
2.6 Influence of Screening History on Black Women’s Screening Behaviors
Despite these programs, racial inequities in the time between BrCa detection and
diagnosis persist.15,16,79,83,85,92,109 The enduring nature of BrCa screening inequities points
to gaps in understanding how various factors influence BrCa screening behaviors in
Black women. Much of the research on this phenomenon examines BrCa screening
knowledge, cultural beliefs, structural/logistical barriers to screening, but few studies
have examined the role of past screening history.24,87,88,112 One screening outcome that
has received little attention, but may hold the key to explaining delayed follow-up among
Black women, is receiving a FPM.
Black women’s history of abnormal mammography results may be an important,
but understudied aspect of their screening experience. One qualitative study of Black
BrCa survivors presented accounts of women who delayed seeking care for lumps due to
past abnormal screening mammograms that were found to be non-cancerous.34 Another
study by Kerner et al. examined correlates of delayed follow-up in a sample of Black
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women with abnormal screening mammograms.35 Women who completed
mammography follow-up after the 90-day window were more likely to have had an
abnormal mammogram in the past, displayed higher levels of anxiety compared to those
completed follow-up within the window, or had a screening mammogram designated as
incomplete or inconclusive compared to those designated as highly suspicious or
potentially malignant (BI-RADS 0 vs 4/5).35 Both studies indicate a possible connection
between prior abnormal mammograms and mammography delay in Black women.
2.7 Definition and Epidemiology of False Positive Mammograms
FPM is the term used in public health research to describe a screening
mammogram with an abnormal result that is confirmed as non-malignant through one or
more of the following procedures: diagnostic mammogram, ultrasound, breast MRI, or
biopsy.37,113,114 Clinically, FPM results correspond to a BI-RADS classification of 0
(Incomplete - additional imaging evaluation and/or comparison to prior mammograms in
needed), 3 (Probably benign finding), 4 (Suspicious abnormality) or 5 (Highly suggestive
of malignancy).39 Normal mammograms are classified as BI-RADS 1 or 2.39
Anywhere from 5-10% of mammograms each year result in a FPM, but
cumulatively a woman has a 20-65% chance of receiving a FPM result depending on the
age at which she initiates screening (anytime between 40 and 50 years of age) and her
screening schedule (annual vs. biennial).37,41–43,114,115 FPM may lead to potentially
negative outcomes, such as additional financial costs due to follow-up testing, impaired
daily function, negative emotional states, and potentially reduced BrCa screening
intention and behavior.37,38 Patient and system level factors can increase the rate of FPM
results.114,116,117
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2.7.1

Influences on False Positive Mammography Rates
Biological patient characteristics, such as older age, breast density (as measured

by BI-RADS density classification), being premenopausal, having a family history of
BrCa, and for women in the 40-59 age range a low BMI, have been associated with
increased likelihood of receiving FPM results.45,114,118 Several aspects of a patient’s
previous screening history also lead to future FPM results: having a FPM result in the
past, if this the patient’s first or subsequent screening mammogram of her BrCa screening
life, the availability of previous mammography images, and shorter screening
intervals.45,114,118,119
Provider and facility characteristics also drive FPM rates, but is not entirely clear
how these factors influence FPM rates at the mammography facilities Black women
use.46,120–125 Radiologists who were older, male, with more clinical experience, or read
less than 1,500 scans annually had lower FPM rates.47,122,123,125 Additionally, completing
a breast imaging fellowship and reporting concerns about malpractice was associated
with higher FPM rates among radiologists.47,122 One study documented radiologists
recalling Black women for additional testing at higher rates than White women, but it not
entirely clear if this is related to variations in screening history between Black and White
women.124 Facility-level characteristics, such as providing radiologists with audit data,
the presence of on-site diagnostic, specialized imaging procedures, and interventional
services, were also related to higher FPM rates.120–122
Many of the factors associated with high FPM appear to be more prevalent among
academic medical centers and facilities with National Consortium of Breast Centers
accreditation or American College of Radiology’s Breast Imaging Center of Excellence
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certification.126,127 Yet, Black women are less likely to attend facilities with the
previously mentioned credentials when compared to White women.128 Recent studies
have demonstrated that mammography facilities that serve higher percentages of women
of color have higher FPM rates, even after adjusting for patient characteristics .46,120
Together, this evidence points to an interplay between Black women’s screening history
and BrCa screening environments leading to higher levels of FPM results, but the ways in
which these dynamics impact Black women’s emotions, beliefs, and behaviors around
BrCa has been left out of research on FPM results.
2.8 Current Research on False Positive Mammography Outcomes
2.8.1

Populations Studied
Studies of this phenomenon begin appearing in the late 1980’s after notable rise in

mammography screening rates (and preceding a subsequent recommendation for women
ages 40-49 not to participate in screening mammography).129,130 Multiple reviews of FPM
studies were published between 1997 and 2010.37,38,131–133 Research on FPM has been
conducted primarily with homogeneous samples of European women.37,38,43,131,133–144
Research on the impact of FPM among American women includes samples of primarily
White, middle to high income, college-educated women.37,38,43 Only a handful of
American studies include Black women and examine the impact of FPM by
race.35,43,115,145–155
2.8.2

Explanatory Mechanisms
Except for a recent study by DeFrank et al. (2012), none of the previous research

on this topic tested mechanisms describing how FPM results influence subsequent
screening behavior as the primary focus has been measuring psychosocial outcomes
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including anxiety and depression.43,115,131,147–149,151,153,155–157 DeFrank et al. (2012)
prospectively followed women presenting for mammography to determine how/if
emotions and BrCa screening beliefs influenced mammography behavior. In this study,
women with FPM results were more likely to experience delays in the completion of their
next mammogram and that a mammography recommendation from a provider mediated
subsequent mammography completion in this group.43 Women receiving a FPM result
were less likely to complete their next scheduled mammogram, but receiving a
recommendation from provider reversed this trend.43
2.8.3

Study Design
The majority of FPM studies use national or site-based screening cohorts for

study, but the rarity of FPM results in a given screening year makes the use of a casecontrol design a less time and resource intensive option.37,43,158–171 Of the handful of casecontrol studies conducted, only one study by Lowe mentions the selection of matching
controls to create a sample in which demographic characteristics are comparable in
women with FPM and normal mammography results.115,151,172–177 The lack of unmatched
case-control studies presents doubts as to the validity of FPM study outcomes as findings
maybe a result of demographic differences between cases and controls.
The body of research on FPM results is not without several strengths. An
important strength is the reliance on prospective studies which confirm a temporal
relationship between FPM and psychological outcomes.37,43,115,158–168,170,172,173,175,178–181
Another positive aspect of this work is the vast number of longitudinal studies assessing
participants shortly after receipt of results and following participants, in some cases, for
two years after their initial FPM result. 37,43,159–162,164–170,175–178,181 Approximately one-
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third of these studies provide information on the longer term impact of FPM results
(greater than 6 months after receipt of results) and report differences between women
with FPM and normal results.37,43,165,166,169,170,175,177,178,181
2.8.4

Outcomes Assessed

2.8.4.1 Emotions
Anxiety was the most commonly assessed outcome across all studies of this
phenomenon.37,38,131–133 General anxiety was consistently measured with one of three
standardized measures the Hospital Anxiety and Depression Scale, the Spielberger StateTrait Anxiety Scale-State Subscale, or the General Health Questionnaire.37,38,182–184 While
standardized measures have detected higher levels of anxiety among women with FPM
results, these differences were largely not statistically significant.37,38 On the contrary, a
substantial number of studies using ad hoc measures of general anxiety report statistically
significant differences.37,38 BrCa specific-anxiety has been measured by a combination of
investigator developed measures and the anxiety subscale of the Psychological
Consequences Questionnaire (PCQ).38,179 The association of elevated levels of BrCa
specific-anxiety and FPM results persists no matter what assessment was employed.37,38
Emotions similar to anxiety, including worry, fear, and intrusive thoughts have
been examined to a much lesser extent and with largely single item questions developed
for individual studies.37,38 As with BrCa anxiety, measures of worry and fear that are
specific to breast cancer document higher levels of these emotions among women with
FPM results.37,38
Depression often co-occurs with anxiety and has frequently been assessed in
studies of FPM mammography.37,38 A wide variety of standardized scales have been used
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to measure the potential depression among women with FPM results, including: the
Hospital Anxiety and Depression Scale, the Hopkins Symptom Checklist, the Depression
subscale of the General Health Questionnaire, the K-6 Questionnaire, the Beck
Depression Inventory, and the Short Form of the Center for Epidemiologic Studies
Depression Scale.37,38,183–188 Yet, the literature on this topic displays a lack of association
between FPM results and depression.37,38
Various aspects of psychological distress and somatization in response to FPM
results have been documented with mixed results.37,38 Physical, emotional, and social
distress, as measured by the PCQ, has consistently been associated with FPM status, but
other scales have not yielded the same results.37,38 There is no clear consensus regarding
the relationship between physical complaints and FPM status given the different types of
complaints assessed by each scale.37,38
2.8.4.2 Breast Cancer Beliefs
Despite the role of BrCa related beliefs and intentions in understanding BrCa
screening behavior, less than a third of studies investigate the potential impact of
receiving a FPM result on BrCa screening beliefs and attitudes.43,112,149,153,163,167,168,178,189–
191

Components of the health belief model have been assessed in various studies with

perceived BrCa susceptibility being the most frequently examined
belief.43,149,151,153,163,167,168,191 The impact of perceived susceptibility is inconclusive with
half the studies measuring this belief reporting statistically significant increases in
perceived susceptibility among women with FPM results, while the remaining studies
report no relationship between these variables.43,149,151,153,163,167,168 One study by Molina et
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al. (2017) revealed the influence of FPM status on perceived susceptibility varied by race,
with higher levels among Latinas and no differences among White women.191
Only four studies measured perceived benefits of mammography, but neither used
a standardized scale.37,43,177,178 DeFrank et al.’s (2012) study of FPM results and
subsequent mammography behavior found that FPM status was associated with more
time thinking about the benefits of mammography.43 Gram et al. (1990) and Brett et al.
(2001) found no association, while Lerman et al. (1991) did not report an analysis of
these factors.151,177,178 Pisano et al. (1998) and DeFrank et al. (2012) were the only studies
to examine how the perception of barriers to mammography may vary by mammography
outcome, and neither detected a statistically significant relationship.43,149
2.8.4.3 Breast Cancer Screening Intentions and Behavior
Screening intention is an important precursor to mammography screening, but this
concept only been measured in two studies to date.163,192 Lerman et al. (1991) found that
FPM was associated with increased mammogram screening intention, in contrast to Brett
et al. (1998) which found no association.163,192 These mixed findings do not extend to the
impact of FPM results on BrCa screening behaviors. FPM status has overwhelmingly
been associated with higher rates of breast self-examination rates.37,166,167,169 The impact
of FPM status on subsequent mammography screening varies by region, with FPM status
reducing the likelihood of White European women completing mammograms and
increasing the likelihood of mammography completion among American women.37 FPM
status did not affect mammography behavior among Canadian women.37 Regional
differences in the influence of mammography outcomes on future mammography
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behavior speaks to the influence of additional factors on this relationship, specifically
health system characteristics.
2.8.5

Influences on False Positive Mammography Outcomes

2.8.5.1 Mammography Satisfaction and False Positive Mammography
Much of the research on mammography satisfaction has been conducted in
international settings and centers on the influence of patient-level characteristics like age,
education, and income.89,193 Facility features, such as the patient volume, payer mix,
geographic location, clinical environment, and provider-level factors, including the
communication of information about the screening process, and perceived staff
competence, are described as having an important effect on satisfaction in several
qualitative studies, but quantitative analyses of these characteristics are limited.194–196
Both Ong et al. (1997) and Brett et al. (2001) examined how the receipt of FPM results
relate to mammography satisfaction.158,178 Ong et al.’s (1997) analysis found relationships
between increased anxiety displayed by women with FPM and poor communication, the
need for additional information about screening outcomes, and difficulty understanding
screening results.158 In the case of Brett et al. (2001) no information was given about the
measure of satisfaction, but incomplete/poor communication about screening results and
longer wait times were associated with dissatisfaction with the clinical encounter among
women with FPM results.178
2.8.5.2 Coping Behaviors and False Positive Mammography
In the case of BrCa, the majority of studies examine coping in the context of BrCa
treatment and survivorship, but some research indicates that coping behaviors may also
play a role in breast cancer screening.197,198 In response to a hypothetical BrCa diagnosis,
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Black women, White women, and Latinas from multiple countries reported their
anticipated coping styles in addition to the number of mammograms completed in the
past 10 years.198 Avoidant coping behaviors were found to be associated with lower
mammography rates among Black American women, but the direction of this association
differed within racial groups (Blacks from the Caribbean) and between racial groups
(Blacks vs Latinas).198
A single study by Chen et al. (1996) sought to determine the effect of various
coping behaviors on psychological stress experienced by women with FPM results.180
Coping strategies appear to be assessed using an early version of the Ways of Coping
Scale, which measures primary, secondary and tertiary coping responses.180,199 Chen used
stepwise regression to determine what characteristics mediate/explain the connection
between FPM results and negative psychosocial outcomes.180 Problem-focus engagement
behaviors (confronting an issue) were related to lower levels of psychological distress,
while neuroticism, as measured by Eysenck’s Personality Inventory, was associated with
higher levels of distress.180
Conceptualizations of coping behaviors have their roots in the transactional model
of stress and coping.200 This model stipulates that multiple interdependent processes are
generated when an individual encounters a stressor.200 In the case of FPM result, the
characteristics of the event are evaluated during the primary appraisal process, which
may generate an initial emotional response such as anxiety.200,201 Simultaneously,
secondary appraisals are employed to determine a course of action, which usually leads to
a coping response.200,201 Coping strategies can generate new emotions and beliefs in and
of themselves or through the new appraisals that are generated in response to the coping
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behavior.200,201 Individual characteristics including personality traits and cultural
differences in social contexts and emotional expression can greatly impact this process.201
Personality traits have been shown to impact appraisal outcomes with negative
traits such as neuroticism leading to potentially less productive avoidant-style coping
behaviors.202 Additionally, the meaning and usage of coping behaviors vary across racial
and ethnic groups and in response to different events.203–205 Black American culture has
retained an emphasis on collectivism, religion, and spirituality thus shaping Black
women’s coping strategies .203–206 The use of culturally appropriate coping assessments
such as the Africultural Coping Systems Inventory (ACSI) may be necessary to
accurately describe Black women’s coping behaviors in the face of a FPM result.204,206
2.9

Gaps in Research on False Positive Mammography Results
All of the systematic reviews conducted on this topic have described weakness

related to measurement and external validity.37,38,131,133 Additional challenges present in
FPM studies include: a lack of research on explanatory mechanisms and an
overemphasis on individual-level factors (to the exclusion of the healthcare
environment).
2.9.1

Issues with Study Design and Measurement
Of the standardized measures that have been consistently used to examine

anxiety, the following are the most commonly used: Psychosocial Consequences
Questionnaire (PCQ), Hospital Anxiety and Depression Scale (HADS), General Health
Questionnaire (GHQ), and the Spielberger State-Trait Anxiety Instrument (STAI). GHQ,
HADS, STAI are clinical measures and may not be sensitive enough to capture the levels
of anxiety present during the screening encounter.133 The commonly used measure of
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BrCa anxiety: the PCQ and the revised version of the measure (PCQ-DK33) have been
used almost exclusively in European studies, so the psychometric properties of this
measure with American women is unknown.207 Reliance on cohort designs, self-report
data, and the small numbers of women with FPM results are methodological limitations
of this body of work.133 Even more recent work while well designed, uses unstandardized
measures and/or and has failed to generate mechanisms describing the link between FPM
results and BrCa screening behaviors .43,115
2.9.2

Issues with External Validity
All of the studies mentioned thus far provide important information regarding the

outcomes of receiving a FPM result, but many of them are not generalizable to American
populations, including Black women. The impact of FPM on the screening behaviors of
Black women has been largely ignored as the majority of research on this topic has been
conducted primarily with homogeneous samples of European women.37,38,43,131,133–144
Research on the impact of FPM results among American women include primarily
White, middle to high income, college-educated women.37,38,43 Only a handful of
American studies include Black women and examine the impact of FPM by
race.35,43,115,145–155
2.9.2.1 False Positive Mammography in Black Women and Other Women of Color
While Black women’s experiences with BrCa screening have been explored indepth, only one study has sought to understand how Black women’s screening behaviors
relate to various screening endpoints such as the receipt of FPM results. Kerner et. al.
(2003) examined multilevel influences on diagnostic delays in Black women and found
that women with previous FPMs were 60% more likely to have diagnostic delays than
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Black women without a history of FPMs.35 Additionally, Black women in this study with
higher levels of cancer anxiety were less likely to complete their diagnostic follow up
within the recommended 90 day window.35
When comparing the effects of FPM in non-White and White women, Gibson et
al. (2009) found no difference in anxiety levels overall, but upon reviewing outcomes by
race, non-White women exhibited significantly higher levels of anxiety if they had
received a FPM result.150 Across racial categories, women in the FPM group with higher
anxiety scores were more likely to display depressed mood.150 Black women only
comprised 0.20% of the sample, so it is likely that these results were driven by the Latino
women in the study.150
Alderate et al. (2006) reports that Asians were less likely than Whites and Blacks
to be depressed in the 3-7 months post receipt of FPM result.145 The study also revealed
that women who reported weekly attendance at religious services during that time were
less likely to experience depression, but this and other factors correlated with increased
depression (having a disability) were not examined separately for each racial group.145
Alderate et al. (2006) also included women whose abnormal results were revealed to be
malignant, so it is questionable how well this study describes the effects of FPM across
racial and ethnic groups.145
While these studies suggest potential negative outcomes of FPM results in Black
women, with the exception of Kerner et al. (2003), they do not provide insights as to how
the FPM process may contribute to racial inequities in BrCa screening being that they
compared the emotional states of Black women to other groups of women as opposed to
describing the process of and impact of FPM in Black women. Additionally, these studies
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do not describe the mechanisms by which emotional states, knowledge, attitudes, and
beliefs influence mammography intention following the receipt of a FPM result in Black
women.
2.9.3

Inattention to Mechanisms Explaining the Outcomes of False Positive
Mammography
Except for Lidbrink et al. (1995) and Molina et al (2014), none of the previous

literature on this topic examined what factors mediated psychosocial outcomes of
receiving FPM results nor have they empirically tested mechanisms connecting various
psychosocial outcomes of FPM results with future mammography intention.43,115,131,147–
149,151,153,155–157

As psychosocial factors such as emotion, personality traits, and stress

response are embedded in cultural contexts, it is important to examine the impacts of
these factors within a specific cultural group in order to explain their effects on health
behaviors.208 Blacks and members of other more collectivist cultures have been shown to
rely more heavily on external resources leading to potentially different reactions and
outcomes than Whites in similar situations.203,206 Incorporating examinations of
culturally-specific coping strategies, such as the Africultural Coping Systems
Framework, in response to the receipt of FPM results and can provide important insights
as to how Black women respond to this phenomenon.206
2.9.4

Inattention to the Influence of Socioecological Contexts of the Healthcare
System
The socioecological model of health describes the influence of intrapersonal,

interpersonal and system level factors on health outcomes as well as racial inequities in
cancer screening behaviors.209,210 Patient-level influences on BrCa screening behaviors in
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Black women are well documented and include: BrCa knowledge, beliefs and
attitudes.24,211 In FPM research conducted with US women (primarily White), trait
anxiety, mood states such as general and BrCa specific anxiety, depression, and coping
styles have been found to be associated with FPM status.43,115,131,147,148,151,153,155,156 Yet,
only a handful studies have empirically tested the mechanisms linking psychosocial
outcomes to mammography screening behavior.43,169,178
Health system factors shape clinical encounters directly through impacting patient
experiences and indirectly by shaping provider practice.212,213 Appointment availability,
referral processes, norms of provider and staff behavior, the method and manner that
mammography results are communicated, all impact on women’s mammography
experiences and their satisfaction with these experiences.156,213–215 Facility-level factors
including but not limited to patient volume, payer mix, facility capacity, can impact
providers’ behaviors such as the duration and type of communication they are able to
engage in during a visit.35,213–220 Despite theoretical and empirical knowledge of the
multilevel influences on mammography and mammography satisfaction, few studies have
explored these combined influences on mammography or FPM outcomes.215,221 As with
investigations of FPM outcomes, mammography satisfaction among Black American
women has received little attention outside of evaluations of patient navigation
programs.195,222,223 This dissertation research is novel as it employs quantitative and
qualitative research methods to explore and explain the interaction of various
socioecological levels during the FPM process and how these factors influenced Black
women’s mammography screening intention.
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2.10 Statement of the Problem
Black women are less likely to complete the entire BrCa screening process, as
they are less likely to return when recalled for a mammogram leading to delays in
diagnosis and treatment.15,16,19,27,83–85,224,225 Understanding what factors influence Black
women’s behavior during the BrCa screening process can make important contributions
toward reducing racial inequities in breast cancer burden, yet we do not know how Black
women’s BrCa screening behaviors are impacted by their experiences with different
BrCa screening pathways, such as receiving a FPM result.
The concept of intersectionality along with the frameworks of critical race theory
and womanism can be applied to this issue to determine how the unique features of Black
women’s lives shape their health outcomes via their physical and social environments.226–
229

Intersectionality highlights the fact that groups such as Black women face multiple

intersecting categories of marginalization that shape their life experiences.229 As a result,
Black women face different barriers due to the way that racism impacts the perceptions of
their womanhood and vice versa.229 Womanism offers a balance to the concept of
intersectionality by emphasizing the different sources of strength that Black women can
tap into as they combat racism, sexism, and other potential sources of
disenfranchisement.226,230 Critical race theory ties these two perspectives together by
recommending that studies of health issues in marginalized groups, such as Black
women, center their experiences and voices, and accounts of the social and cultural
characteristics that are unique to their lives.
Black women’s lives are grounded in different healthcare, social, and cultural
environments leading to differential BrCa risk, incidence and mortality.56 Black women
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are diagnosed with BrCa at younger ages due to accelerated aging as result of exposure to
discrimination (the Weathering Hypothesis).231 Additional evidence also links
discrimination with increased BrCa incidence in Black women.232 Discrimination in the
form of institutional racism restricts Black women’s access to heath promoting resources
through residential segregation.233,234 Research indicates that Black women are less likely
to live near mammography facilities and/or facilities that demonstrate high-quality BrCa
screening services, which may also impact tumor stage at diagnosis.128,233 Racial
segregation has also been shown to impact Black women’s mammography follow-up
times.235
These challenges do not end once Black women access healthcare facilities. Due
to historical abuses and past experiences with discrimination, Black women may be
hesitant to trust providers leading to lower levels of satisfaction and worse healthcare
outcomes.31,222 Studies of healthcare provider behavior demonstrate the persistence of
implicit bias and its negative influence on providers’ communication and interactions
with Black women.59,61,62,236
In addition to navigating the larger dominant culture, Black women must also
negotiate Black American culture and its accompanying social and cultural norms. Black
women’s connection to their communities can function as a source of resources and
support in times of need, a way to maintain agency during adversity, or a means of
avoiding or denying unpleasant realities.63,237 The archetype of the “Strong Black
Woman” allows women to bond through offering help, but it also limits the level to
which Black woman engage in self-care as they must “be everything to everybody”
leaving little time for physical and mental health maintenance behaviors.63,237 The strong
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influence of family and community relationships also has potential implications for
overcoming the deficits in health promotion resources and knowledge that so many Black
women must overcome to improve their health.63,237,238
These features of Black women’s lives underscore the need for research devoted
to the discovery of deep cultural factors that underlie health and lead to the development
of culturally competent solutions.65,239,240 Much health research uses primarily White
populations for theory and intervention development, and the cultural assumptions
embedded in such work are often not applicable to Blacks.241,242 Increasing racial equity
in cancer control, and specifically BrCa burden, requires conducting research with Black
populations to examine the multilevel factors that contribute to racial inequities they
experience.243
2.11 Study Purpose
The purpose of this study was to understand the processes associated with FPM
results and their impact on BrCa screening intention in Black women using a mixed
methods study design. This study had two specific aims:
1) To describe, using a mixed methods approach, the organizational and provider-level
characteristics of mammography facilities and their impact on Black women’s FPM
experiences and outcomes.
2) To determine, through quantitative methods, the relationship between receiving a FPM
result and future mammography intention among Black women.
This research has the potential to make significant contributions to cancer
research by enhancing our knowledge of a common BrCa screening pathway, the one
ending in a FPM result, and its role in racial inequities in BrCa burden. Several aspects of
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the research design make this study novel in comparison to other examinations of this
phenomenon. Empirical data linking organizational, provider, and patient level features
to BrCa outcomes was generated and used to contextualize the ways in which these
factors can perpetuate or inhibit racial inequities in cancer burden. The integration of
relevant behavioral theories such as the transactional model of stress and coping and the
health belief model will allow for the understanding of the mechanisms responsible for
the influence of FPM results on subsequent BrCa screening intention. A rigorous study
design with the use of a case-control study and culturally-appropriate standardized
measures was used to determine how FPM results influenced Black women’s BrCa
screening beliefs and attitudes. Previously unknown contributors to delays in diagnostic
resolution among Black women maybe revealed as a result of this investigation. Given
the role that diagnostic delay plays in Black women’s increased BrCa mortality, the
results of this study may yield new insights as to the causes of racial disparities in BrCa
screening behaviors.
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CHAPTER 3
METHODOLOGY
This chapter contains a description of the conceptual model guiding the study.
Details of the study design, data collection methods, sources, and measures are all
provided in this chapter. The connections between the conceptual model, specific aims,
data collected and analyses conducted are also explained in this chapter. The purpose of
this study was to determine the impact of organizational, provider, and individual-level
factors on the processes and outcomes associated with FPM results in Black women.
3.1 Overview of Study Design
This study had two specific aims:
1) To describe, using a mixed methods approach, the organizational and providerlevel characteristics of mammography facilities and their impact on Black women’s FPM
experiences and outcomes.
2) To determine, through quantitative methods, the relationship between receiving
a FPM result and future mammography intention among Black women.
This study consisted of two phases. Phase 1 featured the collection of facility and
provider level data. Qualitative (observations, key informant interviews) and quantitative
(medical records review) methods were used to collect data about the organizational
features of the participating mammography facilities. A quantitative survey tool was
created and distributed to mammography facility staff members via paper packets, flyers,
and email messages. Provider demographics, perceptions of women’s mammography and
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FPM experiences, and providers’ communication about these topics were assessed using
the survey tool.
Phase 2 of the study consisted of the administration of a survey via postal mail to
a cohort of Black women completing screening mammograms at one of the five
participating mammography facilities. Cases and controls were selected from medical
records and sent a packet containing a paper survey and a medical record release form.
Patient sociodemographic information, mammography experiences, emotional states, and
coping behaviors were assessed via survey. Medical records were requested for women
returning a signed release form and used to confirm mammography screening history and
final screening results. Phase 2 was linked to Phase 1 data and the resulting dataset was
used to answer research questions for both Phases of the study.
3.2 Conceptual Model
This research study was guided by the conceptual model presented in Figure 1.
The model is based on empirical evidence and components of the multilevel context of
cancer care model for abnormal mammograms, the transactional model of stress and
coping, and the health belief model.200,244–246 Figure 3.1 depicts how organizational
factors directly and indirectly through provider interactions impact women’s
mammography experiences. Personal characteristics, i.e., race, age, education, shape how
women interpret their mammography experience (specifically receiving a FPM result)
and influence their beliefs about the BrCa screening. The relationship between Black
women’s behavioral beliefs about BrCa screening and their FPM status will be explained
by their emotional responses to receiving a FPM result. In other words, the distress
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Figure 3.1 Conceptual Model

created by receiving a FPM will shape their beliefs about BrCa screening and
subsequently their attitude towards completing screening and follow-up procedures in the
future. Coping strategies will also be generated and will have a moderating effect on
BrCa behavioral beliefs.
The multilevel context of cancer care model for abnormal mammograms informs
the framework by indicating the various levels of influence that impact mammography
screening behavior: organization/practice setting, healthcare providers, and individual
patients.244 Study variables are displayed in the conceptual model under their
corresponding socioecological level. The model describes the various steps from the
completion of the screening test to initiating diagnostic testing and the referral to
treatment, if needed. Multiple tasks are required to resolve this process and this model
describes how factors at the organizational, provider, and individual level can affect the
successful completion of each task in the follow-up process.
Each mammography facility has an organizational structure, resources, and
communication pathways which influence its day-to-day operations. A portion of these
factors (capacity, patient demographics, patient load, scheduling and notification
processes) are included in the “Organization/Practice Setting” section of the conceptual
model. Mammography facilities have a direct impact Black women’s mammography
experiences through system level factors and indirectly through health providers.
Through their training, communication behaviors, attitudes towards
mammography, and their perceptions of patient’s mammography experiences; healthcare
providers impact women’s clinical encounters just as healthcare providers are impacted
by the organizational structures of their workplaces. Mammography and primary care
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providers influence Black women’s mammography experiences through similar factors,
but primary care providers also have the responsibility of recommending mammography
screening. Healthcare providers’ characteristics are listed by provider type under the
“Healthcare Provider” heading in the conceptual model.
Relationships between several individual patient characteristics are displayed in
the “Individual Patient” section of the conceptual model. A variety of individual level
factors interact to shape how women perceive the mammography experience and their
responses to that experience. Demographic characteristics, such as age, education, marital
status, employment status, income, and health insurance status impact not only where
women access BrCa screening services, but how they are treated during the clinical
encounter. Other factors such as the presence of an anxious personality and/or levels of
social support can shape how women react to the mammography experience. A woman’s
BrCa screening history and her previous experience with receiving a FPM results are
additional factors that will impact her perception of her current mammography
experience and thus impact her beliefs about mammography, BrCa screening, and cancer
prevention, in general. It is these BrCa related beliefs that impact a woman’s intention to
complete future screening procedures and/or follow-up on future inconclusive results. A
reduction in mammography intention will lead to lower rates of initial mammography
screening and mammography follow-up. Delays in diagnosis and detection can lead to
increased rates of advanced stage BrCa and BrCa mortality.
The relationship between a woman’s perception of the mammography experience
and her beliefs about BrCa screening/mammography may vary by her reaction to the
mammography experience (receiving a FPM result). The transactional model of stress
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and coping states that people complete primary and secondary appraisals which inform
the actions they take when confronted with stressful events.200,201,245
Primary appraisal generates emotions, but the types of emotions generated depend
on the features of the event.201 Receiving a FPM result is an external event that is
relevant, significant, and uncontrollable, which are characteristics typically lead to fear
and/or anxiety.201 A secondary appraisal takes place where the individual adopts a coping
strategy to deal with the event.200,245 While the appraisal process is described in a linear
fashion, in practice is it not.200,201 As new information is obtained new appraisals are
made, new emotions are generated, and new coping behaviors maybe adopted.200,201
Additionally, coping behaviors can influence new appraisals and beliefs related to the
event in question.200,201 In the context of FPM results, new appraisals maybe be generated
at each point in the process, the employment of coping behaviors has the potential to
change a women’s attitude toward the behavior (benefits and barriers to mammography)
and her susceptibility to BrCa. These constructs of the health belief model have been
shown to impact future mammography intention in Black women, thus if FPM impacts
mammography intention it likely through these beliefs.88,189,247
3.3 Specific Aim 1
To describe, using a mixed methods approach, the organizational and providerlevel characteristics of mammography facilities and their impact on Black women’s FPM
experiences and outcomes.
Research Question 1.1. What organizational, provider, and patient-level
characteristics predict high levels of satisfaction with their clinical encounter among
Black women experiencing a FPM result?
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Hypothesis 1.1. Mammography facilities with lower screening capacities, higher
diagnostic capacity, which employ more patient management systems, have fewer
“patient friendly features” in their clinical environments, and have more providers
reporting low perceptions of women’s distress about FPM will lead to higher levels of
satisfaction with the clinical encounter among Black women experiencing a FPM result.
3.3.1

Setting
This research study was conducted in collaboration a leading provider of

mammography services in the Columbia, SC MSA which diagnoses roughly 70% of the
total BrCa population in the area.79 The Columbia, SC MSA consists of the city of
Columbia and its surrounding counties with an estimated population of 776,794 (of
which 66,358 were Black women over the age of 35) in 2013.248 Screening
mammography is offered in four in ambulatory care centers and via a mobile
mammography van servicing communities across the state (See Figure 3.2).
Between June 2013 and June 2014, 38,500 women completed screening mammograms in
the health system. Across the system, 2,456 (6.3%) women were recalled for additional
follow-up testing, and 248 women were diagnosed with cancer. Approximately 30% of
women with FPM results were Black, 29% were in the 40-49 age range, 36% were in the
50-64 age range, and 16% were 65 and older. A little over 50% of women completing
screening mammograms lived within the city of Columbia, and 90% of them resided in
the Columbia MSA.
3.3.2

Data Sources and Collection Methods
The Palmetto Health Institutional Review Board approved the study protocol on
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Figure 3.2 Locations of Participating Mammography Facilities in Richland County, South Carolina

February 22, 2016 and the Palmetto Health Administrative Review approval was granted
on February 26, 2016 (See Appendix A). Participant observations, key information
interviews, provider surveys, and screening record reviews were conducted during Phase
I. Participant observations and key informant interviews began March 2016 and
concluded August 2016. Provider surveys were fielded from April 2016 to August 2016.
Screening records were collected from June 2016 through October 2016. Organizational
measures and provider survey domains are presented in Figures 3.4 and 3.5. The
variables incorporated in Phase I analyses and the methods used to collect this data are
described below.
Observations. Patient and clinical settings were observed at each mammography
facility for one to three hour sessions to capture information about each facility’s
processes and procedures. Observations were unstructured. Patient-provider, patientpatient, and provider-provider interactions were recorded during observations.
Descriptions of the physical surroundings were also captured during observations. Times
and locations (waiting rooms vs clinical care areas) were rotated to gain a comprehensive
view of site procedures. Observations were recorded via handwritten or electronic notes.
Observation notes were manually transcribed and imported along with electronic notes to
NVivo 11.
Key informant interviews. Interviews were conducted with imaging supervisors
and coordinators at each mammography facility to collect information about facility
characteristics such as reporting structure, equipment, staffing, notification procedures,
hours of operation, and services offered. Responses were recorded on a structured
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Figure 3.3 Organizational Level Measures
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Figure 3.4 Provider Survey Measures

interview form (See Appendix B) and the resulting information was recorded in a
Microsoft Excel spreadsheet.
Retrospective mammography screening data. Demographic information (date
of birth, race, health insurance product and zip code) and mammography screening
outcomes (procedure, procedure date, procedure type, BI-RADS rating, and facility) for
women completing screening mammograms from January 2016 to August 2016 were
requested from the Palmetto Health Radiology Department on a monthly basis. Data was
imported into STATA 13 for data management and analysis. Visits were matched
medical record number to create a visit history for each patient. Data were analyzed in
aggregate to generate facility characteristics such as patient volume, and patient
demographics.
Mammography provider surveys. Physicians and staff members at all 5
facilities (n=46) were asked to complete a survey about their experiences with
mammography screening and their perceptions of women’s mammography experiences
(See Appendix C). All individuals designated as having patient contact and who worked
in a Palmetto Health mammography facility for at least six months prior to the start of the
study were eligible to participate in the survey. Participants were recruited using e-mail,
flyers, word of mouth, and project presentations at staff meetings. Survey participants
were entered into a giveaway to receive one of 10 $25 gift cards after the survey was
concluded.
The survey consisted of closed and open-ended items assessing demographic
information (age, gender, race, provider type, professional training) and providers’
perceptions of patients’ physical and psychological comfort used by Nutting et. al. (2001)
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during their evaluation of influences on primary care providers.213 Items from national
surveys of provider communication regarding dementia and aging and studies of genetic
counselors’ communication with patients of different were adapted to assess
communication from the providers’ perspectives.249–251 These items assessed providers’
perceptions of the FPM experience and how providers communicate about this
experience. Staff members completed surveys online or using paper survey packets that
were returned via postal mail. Survey results were imported into STATA 13 and NVivo
11 for interpretation.
3.3.3

Data Management
A data dictionary was developed, and the facility data (observation, key informant

interview, medical records, and provider survey data) were entered into a password
protected spreadsheet using numeric codes. Data for each site were entered using an
identification number. The data file was uploaded into STATA 13 and merged by site
with the patient survey data collected in Phase 2. All notebooks and paper surveys were
stored in a locked file cabinet in a locked office at the University of South Carolina. All
electronic files were stored on password protected laptop in a locked office at the
University of South Carolina.
3.3.4

Data Analysis
All organizational and provider variables were numerically coded and entered into

spreadsheet and analyzed in STATA 13.252 Means and frequencies for organizational and
provider level measures were calculated and chi-square tests and ANOVA were used to
detect any statistically significant differences in organizational and provider
characteristics between sites. Mean values for patient volume, the number of privately
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insured patients, non-White patients, hours of operations, screening procedures and
diagnostic were calculated and used as a cut point to categorize facilities as high or low
for each variable. Features of the clinical environment such as a dedicated waiting room
for follow-up patients, the presence of educational materials, screening navigation,
outreach activities, and free parking were marked as present or absent. Providers’
responses regarding their perceptions of patient’s physical discomfort, psychological
discomfort, and distress about screening and FPM were averaged for each facility.
Associations between organizational, provider level data, and patient satisfaction
data collected in Phase 2 were assessed using linear regression for continuous variables
and ANOVA for categorical variables. The primary analysis for Specific Aim 1 consisted
of bivariate logistic regression models to determine the influence of facility, provider, and
patient characteristics on satisfaction with mammography by mammography outcome
(FPM status vs. normal).
3.4 Specific Aim 2
To determine, through quantitative methods, the relationship between receiving a
FPM result and future mammography intention among Black women.
Research Question 2.1. What is the relationship between receiving a FPM result
and BrCa behavioral beliefs (perceived benefits of mammography, perceived BrCa
susceptibility, and perceived barriers to mammography screening) among Black women?
Hypothesis 2.1. Receiving a FPM result will have an overall negative effect on
BrCa behavioral beliefs in Black women. Specifically, Black women with a FPM result
will report lower levels of perceived mammography benefits, higher levels of perceived
mammography barriers, and higher levels of perceived BrCa susceptibility.
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Research Question 2.1.a. Do Black women’s emotional states explain the
relationship between a FPM result and BrCa behavioral beliefs (perceived benefits of
mammography, perceived BrCa susceptibility, and perceived barriers to mammography
screening)?
Hypothesis 2.1.a. Anxiety and depression will each independently explain the
relationship between receipt of FPM results and BrCa behavioral beliefs.
Research Question 2.1.b. Does the relationship between receipt of FPM results
and BrCa behavioral beliefs (perceived benefits of mammography, perceived BrCa
susceptibility, and perceived barriers to mammography screening) vary by coping
strategy employed?
For Black women with FPM results, women engaging in high levels of
cognitive/emotional, collective, and spiritual coping behaviors will have a positive effect
on BrCa behavioral beliefs. Specifically, Black women with FPM results who engage in
high levels of cognitive/emotional, collective, and spiritual coping behaviors will report
higher levels of perceived mammography benefits, lower levels of perceived
mammography barriers, and lower levels of perceived BrCa susceptibility.
Research Question 2.2. What is the relationship between BrCa behavioral beliefs
(perceived benefits of mammography, perceived BrCa susceptibility, and perceived
barriers to mammography screening) and intention to complete future mammography
screening?
Black women reporting high levels of perceived benefits of mammography, low
levels of perceived barriers to mammography, and high levels of perceived BrCa
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susceptibility will display increased intention to complete future mammography
screening.
3.4.1

Study Design
A survey was designed and fielded to collect data from women completing

screening mammograms for Phase 2 (See Appendix D). Given the low number of women
in the population with the desired characteristic (FPM represented 6% of the screening
patients between June 2013 and July 2014) a case-control study design was employed to
maximize the number of participants with FPM results. Black women aged 40 and older
(evidence indicates that many women were still following the American Cancer Society’s
pre-2015 BrCa screening guidelines and were completing screening mammograms
between the ages of 40-45),253 BrCa free for 5 years or more, no evidence of serious
mental illness, and whose final mammography results were confirmed as benign were
eligible to participate. Patient survey participants were entered into a separate giveaway
for a chance to win one of 10 $25 gift cards at the conclusion of Phase 2.
3.4.1.1 Sampling
Women whose screening mammograms were classified as BI-RADS Category 0
were selected as cases.39 A control participant was selected from eligible women whose
screening mammogram was classified as BI-RADS Category 1 (Negative) or Category 2
(Benign) and occurred on the same day and at the same facility as her matched case.39
3.4.1.2 Sample Size
Only a few US studies have examined the impact of FPM results on future
mammography intention/behavior and they reported small (OR Range: 0.42 - 1.50) to
medium effect sizes (OR 2.12, CI:1.54 -2.93).43,115,147,148,155 With α=0.05, power = 0.80,
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and model with 10 predictors, a sample size of 1,064 would be required to detect a small
effect size and 157 (case and control) participants to detect a medium effect size as
calculated by G*Power.254 Estimating that 20% of surveys will have missing data, a final
sample size of 188 will be needed answer Specific Aim 2.
3.4.1.3 Measures
A 177-item survey tool was used to assess patient demographic information,
previous BrCa screening history, and psychosocial constructs. Domains and scales
included in the patient surveys tool are listed in Figure 3.5. Information describing the
index screening mammogram was collected via survey and compared to the medical
record to ensure accuracy. Measures analyzed for Phase II are described in detail below.
Demographics – Demographic items such as age, education, employment status,
income, marital status, and health insurance status were modeled after items used in the
National Health Interview Survey and the Behavioral Risk Factor Surveillance
Survey.255,256
Breast Cancer Screening History – Items assessing age at initiation of
mammography screening, the receipt of a provider’s recommendation for mammography,
family history of BrCa, and FPM mammography history were used to collect information
about participants’ BrCa screening history. These items were modeled after items from
the National Health Interview Survey.255
Interpersonal Personal Processes of Care Survey: Discrimination and
Disrespectful office staff subscales – The scale measures aspects of provider
communication that were indicated to be important by various racial groups. Experiences
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Figure 3.5 Patient Survey Measures

of discrimination and disrespect during clinical encounters were assessed with the
discrimination and disrespectful office staff subscales, respectively. Validation samples
included multiple racial and ethnic groups, the reliability coefficients for the
Discrimination subscale is 0.79 and for the Disrespectful office staff subscale is 0.90.257
Spielberger State-Trait Anxiety Inventory (STAI): Trait and State Short
Scales – A 10-item scale which measures anxiety as a personality trait and another 10item scale that measures the anxious emotional states. The scale has been validated in a
variety of populations with good reliability (α=0.86 to 0.95).182
CES-D Short Form – This 10-item survey has been validated with many
populations around the world and measures subclinical levels of depression. The short
form has good internal consistency (α=0.75).185
Africultural Coping System Inventory – An African cultural framework guided
this 30-item measure which assesses the use of four coping strategies used by Blacks in
response to a stressful event. The reliability coefficients for the four subscales range from
0.76 to 0.82.206
Champion Attitudes Towards Mammography and Breast Cancer Scale:
Mammography Benefits, Susceptibility and Barriers Subscales – The four-item
Benefits sub-scale is part of a larger scale that examines Black women’s attitudes and
beliefs toward BrCa screening. The four item Susceptibility sub-scale measures
susceptibility to BrCa and is highly reliable (α=0.73).258 The scale’s internal consistency
is adequate (α= 0.73).258 A shortened 10-item version of the original 19 item barriers
subscale was used assess various logistical challenges associated with mammography.258
The original subscale is highly reliable (α=0.89).258
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Cockburn’s Mammography Satisfaction Scale – This 26-item scale was
developed in Australia to measure women’s satisfaction with their mammography
experiences. The scale has six subscales that measure different aspects of satisfaction:
general, convenience and accessibility, provider information transfer, staff interpersonal
skill, physical surroundings, and perceived technical competence.179 The reliability
coefficients for the original scale were low (0.53-0.68), but a modified version has been
used with an American population with good results.207
Psychological Consequences Questionnaire DK-33: Anxiety Subscale (PCQDK33) – The revised version of Cockburn’s Psychological Consequences Questionnaire
contains 33 items which measures women’s psychological responses to screening
mammograms.259 One of these domains, anxiety, is measured with a six item subscale
that has been found to be highly reliable in Danish women (α=0.92), but its use in
American samples is limited.259
Mammography intention – This variable was measured using two ad hoc items:
1) How likely are you get your next screening mammogram as scheduled? and 2) If you
asked to return for follow-up testing after your next screening mammogram, how likely
are you to complete those additional tests? Response categories were 1=Very Unlikely,
2=Unlikely, 3=Likely, and 4=Very Likely.
3.4.14 Survey Administration
Packets containing surveys, medical records release forms, pre-addressed postagepaid envelopes were mailed to eligible patients six months after their initial screening
mammograms to allow for the completion of follow-up testing (July 2016-January 2017).
Reminder letters were sent to participants one month after the mailing of the initial
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survey packet and one month prior to the scheduled end date for the patient survey.
Participants were provided an option to complete the survey over the phone or to call the
principal investigator to recieve get more information about the study. Brief summary
sheets with study contact information were distributed to Palmetto Health staff members
as a reference if women inquired about the study. Medical records were used to confirm
BrCa screening history information and final screening outcomes reported via survey. In
total, 909 survey packets were mailed (411 cases, 498 controls), 25 surveys were returned
to sender, two were found to be ineligible and did not return surveys. Of the remaining
882 surveys distributed, 133 (15.0%) were returned.
Pilot Testing. Surveys were pilot tested in two waves during June 2016. In total,
seven Black women aged 35 and older completed the survey. The first wave consisted of
three members of the research staff, two of whom had previously completed screening
mammograms. After incorporating the feedback from the first wave, the principal
investigator recruited 5 Black women who meet the eligibility criteria, but lived outside
of the Columbia, SC MSA for the second wave. A full-scale pilot was conducted with
survey packets being mailed to participants in the second wave. Additional edits were
made to the survey tool based on the data collected during the second wave.
3.4.2

Data Management
Each survey packet was assigned a participant id which was attached to all survey

materials. All surveys, medical record release forms, and medical records were tracked in
a password protected Microsoft Excel spreadsheet. Survey responses were coded using a
data dictionary and manually entered by participant id into a separate password protected
Microsoft Excel spreadsheet. The data file was uploaded into STATA 13. Paper surveys,
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medical records, and medical records release forms were stored in a locked file cabinet in
a locked office at the University of South Carolina. Medical records were destroyed using
secure data handling procedures after the extraction of required data. All electronic files
were stored on password protected laptop in a locked office at the University of South
Carolina.
3.4.3

Data Analysis
All patient level variables were analyzed in STATA 13. Means and frequencies

were calculated for all variables. Chi Square tests and ANOVA as appropriate were used
determine associations between demographic variables, BrCa screening history, trait
anxiety, state anxiety, BrCa-specific anxiety, depression, coping strategies, perceived
mammography benefits, perceived mammography barriers, perceived BrCa susceptibility
and FPM status. Specific analyses for each research question included in Specific Aim 2
are described below.
Research Question 2.1. What is the relationship between receiving a FPM result
and BrCa behavioral beliefs (perceived benefits of mammography, perceived BrCa
susceptibility, and perceived barriers to mammography screening) among Black women?
Covariates associated with BrCa behavioral beliefs and FPM were used to guide
the construction of ordinary least squares regression (OLS) models developed to address
this research question. OLS models assessing the relationship between each BrCa
behavioral belief (perceived mammography benefits, perceived mammography barriers,
perceived BrCa susceptibility) and FPM status were constructed, and theoretically
important variables expected to influence each BrCa behavioral belief were included in
the model for that belief (e.g. family history of BrCa was included in the model for
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perceived benefits and susceptibility to BrCa). Mean values of BrCa behavioral beliefs
for women with FPM and normal mammography results were calculated using the
average values for the sample with the margins command in STATA. Multilevel
variables such as age category or health insurance status were tested for significance
using the Bonferroni adjustment.
Research Question 2.1.a. Do Black women’s emotional states explain the
relationship between a FPM result and BrCa behavioral beliefs (perceived benefits of
mammography, perceived BrCa susceptibility, and perceived barriers to mammography
screening)?
For OLS models constructed in Research Question 2.1 that were statistically
significant, state anxiety, BrCa specific anxiety, and depression were tested as mediators
using the khb command in STATA. Trait anxiety appeared to function as mediator in
preliminary tests; thus it was included in mediation analyses.
Research Question 2.1.b. Does the relationship between receipt of FPM results
and BrCa behavioral beliefs (perceived benefits of mammography, perceived BrCa
susceptibility, and perceived barriers to mammography screening) vary by coping
strategy among Black women?
For OLS models constructed in Research Question 2.1 that were statistically
significant, coping behaviors were tested as moderators. Interaction terms were created
by centering each variable at the mean value for the sample and incorporating a term into
the model containing the coping style and FPM status. Mean values for BrCa behavioral
beliefs at each level of coping style were calculated using the margins command in
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STATA. These values were plotted and used to determine the presence of effect
modification.
Research Question 2.2. What is the relationship between BrCa behavioral beliefs
(perceived benefits of mammography, perceived BrCa susceptibility, and perceived
barriers to mammography screening) and intention to complete future mammography
screening?
Associations between BrCa behavioral beliefs, FPM, mammography screening
intention, and follow-up intention were used to guide the construction of ordinary least
squares regression (OLS) models developed to address this research question. OLS
models assessing the relationship between each BrCa behavioral belief (perceived
mammography benefits, perceived mammography barriers, perceived BrCa
susceptibility) and mammography intention (screening and follow-up) were constructed.
FPM status and theoretically important variables expected to influence each BrCa
behavioral belief were included in the model describing the relationship between that
belief and mammography intention (screening and follow-up). The mean values for
mammography intention (screening and follow-up) for women with FPM and normal
mammography results were calculated using the average values for the sample with the
margins command in STATA. Multilevel variables such as age category or health
insurance status were tested for significance using the Bonferroni adjustment.
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CHAPTER 4.
RESULTS
This chapter contains the results of the research conducted to examine the
influence of multilevel factors on Black women’s experiences with FPM results and the
impact of that experience on intention to complete future BrCa screening and diagnostic
testing. Manuscript 1 addresses Specific Aim 1, by answering Research Question 1,
through the analysis of the influence of organizational, provider, and patient-level data on
mammography satisfaction among Black women. Manuscript one has been prepared for
submission to the journal Medical Care. Specific Aim 2 and its composite research
questions are described and answered in Manuscript 2. The relationship between FPM
status, BrCa behavioral beliefs, and mammography intentions is explored in Manuscript
2, which will be submitted to the American Journal of Preventive Medicine.
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4.1 Contributions of Mammography Facility, Provider, and Patient Characteristics on
Mammography Satisfaction Among Black Women False-Positive Mammography Status1

1

Farr DE, Brandt HM, Friedman DB, Armstead C, Adams SA, Fulton J, Bull D. To be
submitted to Medical Care
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Abstract
Background. Black women are less likely to complete mammography screening. Prior
screening experiences such as the receipt of false positive mammography (FPM) results
may influence Black women’s satisfaction with their clinical experience and subsequent
desire to complete future screening. Objectives. The purpose of the study is to
understand which facility (environmental), provider, and patient level factors influenced
aspects of satisfaction with the mammography screening experience among Black women
and if FPM status altered these relationships. Research Design. A case-control study was
conducted using observations, medical record data, and surveys. Logistic regression
models were developed to determine influences on different aspects of mammography
satisfaction. Subjects. Participants included mammography facility staff, and Black,
cancer-free mammography patients aged 40 and older who completed index
mammograms between January and August 2016. Measures. The Cockburn
Mammography Satisfaction Scale, which contains six subscales, was the main outcome
measure. Results. No facility, provider or patient factors were associated with two types
of satisfaction: general and provider interpersonal style. FPM status was one of several
patient characteristics associated with lower level of satisfaction with convenience and
provider information communication. Facility and provider level factors had negative and
positive effects on satisfaction with provider competence. Satisfaction with the clinical
environment was also influenced by facility characteristics. Conclusions. Varied aspects
of the clinical encounter influenced Black women’s satisfaction with their mammography
screening experiences. Further research is needed to understand how these clinical
encounters contribute to future screening and diagnostic delay in this population.
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Introduction
Black women have experienced disproportionately high rates of breast cancer
(BRCA) mortality for the past three decades.1 A complex mix of biological, cultural,
economic, and healthcare-related factors contribute to this racial inequity.1 Healthcarerelated factors are critical as they have the potential to impact BRCA stage at diagnosis
through their influence on the timely resolution of abnormal mammography results.2
Delays in mammography follow-up among Black women have been extensively
documented and largely attributed to lower levels of BRCA knowledge and healthcare
access in this population.3,4 The role of Black women's past mammography experiences is
largely absent from research on screening and diagnostic delays. Some evidence indicates
that past false positive mammography results may influence Black women's decisions to
complete follow-up testing after receiving abnormal results.5,6
False positive mammograms (FPM) are defined as abnormal screening mammograms
that are later confirmed as non-cancerous.7 Studies have link FPM with psychosocial
outcomes (e.g. anxiety, depression), BRCA related-beliefs (e.g. BRCA risk, screening
effectiveness, screening intention), and screening behaviors, but the relationship between
FPM and women’s satisfaction with the mammography process has largely been
ignored.7,8 Patient satisfaction has been associated with mammography completion across
diverse populations, but it is unclear how (or if) the process of completing diagnostic
testing influences women's satisfaction with the screening process.9–11 Limited evidence
indicates that satisfaction with aspects of the screening process, such as patient-provider
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communication and quality of care, may differentially impact women who are asked to
return for additional testing.5,12–14 Satisfaction with prior screening encounters among
women with FPM status may influence BRCA screening attitudes and future screening
behavior in this group of women.
Much of the research on mammography satisfaction has been conducted mainly in
Europe and centers on the influence of patient-level characteristics, such as age,
education, and income.15,16 Facility (or environmental) features, such as the patient
volume, payer mix, geographic location, clinical environment, and provider-level factors,
including the communication of information about the screening process, and perceived
staff competence, are described as having an important effect on satisfaction in several
qualitative studies, but quantitative analyses of these characteristics are limited.17–19 As
with investigations of FPM outcomes, mammography satisfaction among Black
American women has received little attention outside of evaluations of patient navigation
programs which seek to support women in the completion of the BRCA screening
process.18,20,21
Given the persistence of mammography delays among Black women, the impact of
facility features, provider interactions, and patient characteristics on Black women's
experiences with FPM and effect on mammography satisfaction warrant exploration. The
purpose of this study was to determine what facility, provider, and patient-level
characteristics predicted high levels of satisfaction among Black women and whether the
factors associated with satisfaction vary by FPM status. Previous studies suggest that
characteristics which many enhance patient-communication and reduce logistical barriers
to screening will be associated with higher levels of mammography satisfaction.
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Specifically, mammography facilities with low screening capacities, with screening and
diagnostic capacity, and more “patient friendly features” in their clinical environments,
and mammography providers who are more sensitive to the distress or discomfort of
women experiencing a FPM will lead to a higher level of mammography satisfaction.
Patients with normal screening results, higher education levels, higher income, and of
older age will be more satisfied with their mammography experience.
Methods
Setting. Study data were collected from five mammography facilities affiliated with a
large hospital system located in the Midlands region of South Carolina. Study activities
were approved by the Palmetto Health Institutional Review Board.
Data Collection. Data collection began in March 2016 and concluded in January
2017. Information about the physical characteristics of and operating procedures at each
facility were collected through key informant interviews and observations. Key informant
interviews were conducted with a supervising staff member at each facility A structured
interview guide with items assessing organizational structure, services offered, clinical,
and notification processes, and the physical environment was used during the interview.
Unstructured observations were conducted to examine clinical processes and determine if
any processes changed during the study period. Observation and interview data were
manually coded by site and entered into a spreadsheet for organization and analysis.
De-identified clinical records were collected for women completing screening
mammograms between January and August 2016. Clinical records provided patient
demographic information (age, race, health insurance product, and zip code) and
mammography screening information (procedure, procedure date, procedure type, BI-
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RADS rating, and facility) for patients screened during that timeframe. All women with
current or previous breast cancer diagnoses were removed from the analysis to examine
influences on satisfaction in the average risk screening population. Patients were grouped
by the facility where they completed their index mammogram, and demographic
characteristics of the patient population were calculated for each facility.
Provider surveys were distributed to clinical and administrative staff at the
mammography facilities via paper packets and online links. Only individuals employed
by a mammography facility for at least six months were eligible to complete the survey.
Surveys were distributed via paper packet during staff meetings and via e-mail to key
staff members. Approximately 40 individuals were eligible for this portion of the study,
and 24 staff members returned the survey for a 60% return rate. Staff members’ age,
gender, race, job title, and education level were collected in addition to questions
examining providers’ clinical experiences. Items assessing perceptions of women’s
experiences with mammography and FPM status were modeled after questions used to
examine primary care providers ratings of patients physical and psychological comfort.22
Survey responses were attributed to the facility (or facilities) where each provider
practiced.
Patients meeting the following criteria were eligible for participation: Black/African
American, aged 40 or older, BRCA free for five years or more, and completed index
screening mammograms between January and August 2016. Survey packets were sent to
potential study participants approximately six months after their index mammogram.
They received reminders one month after the initial mailing and prior to the conclusion of
the study. A case-control design was employed to ensure the recruitment of sufficient

65

numbers of women with FPM results. Women whose index mammogram had a Breast
Imaging Reporting and Data System (B-IRADS) classification of 0 were designated as
FPM. Each FPM was matched to a woman who completed an index mammogram at the
same facility on the same day, but whose final result was BI-RADS 1 or 2. Packets
contained medical records release forms and a paper survey tool. Separate gift card
giveaways were held for participants completing provider and patient surveys to
acknowledge their efforts.
In total, 909 survey packets were mailed to patients with 25 returned due to bad
addresses and two did not meet the racial eligibility criteria. Of the remaining 882
surveys distributed, 133 (15.0%) were returned. Of the surveys returned, five were
ineligible due to recent BrCa diagnoses or serious mental illness and 11 were excluded
from analyses due to missing demographic information or conflicting responses. A final
sample of 117 patient surveys were included this analysis.
Patient Survey Measures. Questions from the National Health Interview Survey
were used to collect information about patient age, education, marital status, and family
history of breast cancer.23 Patient age was calculated using date of birth and collapsed
down to three categories 40-49, 50-64, 65 and older. Education was dichotomized into
either less than a college degree or a college degree or higher. Marital status was
collected as married, living with a partner, widowed, divorced, separated, and single
(never married). Married and living with a partner were reclassified as partnered and the
remaining categories were named unpartnered. Zip code, health insurance status, and
screening facility were obtained from patient medical records. Zip codes were mapped to
counties which were subsequently classified as urban or rural.24 Health insurance
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products were classified as private or public using information from the South Carolina
Department of Health and Human Services website and the National Committee for
Quality Assurance Health Insurance Plan Ratings 2016-2017.25,26
Patient-provider interactions were measured using the discrimination and
disrespectful office staff subscales of the Interpersonal Processes of Care Survey.27 The
scale measures provider communication factors that were indicated to be important by
Blacks and other people of color27 The Discrimination subscale consists of two items that
assess perceptions of discrimination the clinical encounter.27 Four items such as “How
often did office staff talk down to you?” compose the Disrespectful office subscale.27
Responses for both subscales were measured on a 4-point scale with 1 = Never and 4 =
Always.27 Scores were computed by averaging responses. Both subscale scales
demonstrated sufficient reliability in this sample, with α of 0.63 and 0.71 respectively.
Satisfaction with the mammography experience was measured with the Cockburn
Mammography Satisfaction Scale which contains the following subscales: general,
convenience and accessibility, provider interpersonal skills, provider information
communication, physical surroundings, perceived provider competence.28 Each subscale
contains 4 to 5 items measured on a 4-point scale with 1 = Strongly Disagree and 4 =
Strongly Agree.28 Satisfaction scores were generated by summing all responses after
reverse coding negatively worded items. Except for the provider information transfer
scale (α=0.53), all subscales had adequate internal consistency in this survey population
with reliability coefficients ranging from 0.62 to 0.73.
Data Analysis. Facility information and provider survey data were linked to patient
survey responses by screening site. Descriptive statistics (proportions and means) were
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calculated for facility and provider characteristics by site, entered into a spreadsheet, and
merged with patient survey data. Chi-square tests and ANOVA were used to detect site
level differences in characteristics. Multivariable models were constructed to examine the
impact of multilevel characteristics (facility, provider, and individual) on the domains of
mammography satisfaction. As two of the five facilities accounted for the majority of
data, the lack of variability in the sample prevented the creation of stable multivariable
models containing all three levels of data. Bivariable logistic regression models were
used to examine the relationship between factors that would influence the aspect of
satisfaction examined taking account FPM status (e.g. provider communication variables
were not included in models for satisfaction with convenience or the physical
environment). All data analyses were conducted using STATA 13 and statistical
significance was evaluated using an alpha of 0.05.29
Results
Facility Characteristics. Descriptive information for the patient population of the
five mammography facilities is presented in Table 1. Over 25,000 procedures were
completed between January and August 2016 at all sites combined, and the majority of
these procedures were screening mammograms (89%). Site A was the largest site, and it
served a higher percentage of women over the age of 65 and women with public health
insurance. While Site A had equal amounts of White and non-White patients, Site B
similarly had a higher proportion of Black patients specifically (57.6%) and non-White
patients overall (61.8%). In contrast to Sites A and B, Site C is based in a suburban area
and has an increased proportion of older (38.2%), White (75.5%), rural (6.7%), and
privately insured (53.7%) patients. Both screening and diagnostic services were offered at
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Sites A, B, and C, however, Site C offered fewer diagnostic hours per week requiring
patients to wait to complete follow-up testing at Site C or seek care at Sites A or B. As
larger sites, Sites A and B had separate waiting rooms for diagnostic visits and several
exam rooms. Only Site B had internally developed print educational materials about
breast cancer screening available in the main waiting room for women to review. The
remaining sites only provided screening services, and women who required follow-up
were referred to one of the diagnostic sites. Site E represents a mobile mammography
unit that provides services to various institutions across the state (mostly worksites and
community groups). Thus, a much higher number of women completing screening at Site
E were under age 65 (83.4%), White (62.9%), lived in rural areas (15.5%), and had
private health insurance (74.5%).
Provider Characteristics. Twenty-four staff members completed the provider
surveys (demographic data not displayed due having less than 5 observations at some
sites). Responses for staff members who worked at more than one facility were included
in each of their worksites. Provider characteristics were similar across sites with the
majority of respondents being in the 40-60 age range (mean age 47.9 ± 8.91), female
(91.7%), and White (87.5%). All respondents had some elements of patient contact as
part of their responsibilities whether they were radiologists, mammographers or
imagining technicians who perform screening procedures, or patient care
technicians/coordinators who provide instructions and facilitate many aspects of the
clinical encounter. Most respondents had less than a bachelor's degree (70.8%) as
imaging and patient care positions require certification provided by a relevant training
programs. On average, respondents had worked 23.3 years in the healthcare field.
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Across sites, staff members had similar perceptions of women's mammography
encounters (Table 2). Providers reported that women experienced some physical
discomfort (sample mean = 2.5) and psychological distress (sample mean = 2.5) during
the mammography procedure. When asked specifically about women's reactions to
mammography follow-up, most staff responded that Black women were less upset about
having to return for follow-up (sample mean = 3.1) compared to all women (sample mean
= 3.4). The difference in staff members' ratings of distress in response to follow up
approached, but did not reach statistical significance, t(23)=2.01, p=0.05. Site C did
report significantly higher rates of distress for all women (3.9, p=0.04) and Black women
(3.6, p=0.03) compared to the other sites.
Patient Characteristics. Demographic characteristics of the patient survey
respondents are displayed in Table 2. Most of the respondents were in the 50-64 age
range (53.9%), did not have a partner (67.5), had less than a college education (70.9%),
and made less than $50,000 annually (75.2%). A third of respondents (29.9%) reported a
family history of BRCA, and almost half (46.1%) had a FPM result during the study
period. Respondents were well distributed across facilities when accounting for the
demographics across screening sites. Patient satisfaction and provider communication
scores are presented by site in Table 4. There were no statistically significant differences
in scores by site. Mean satisfaction scores were in the middle of the range of possible
scores for each subscale, while mean ratings of discrimination and disrespect during the
clinical counter fell at the low range of scores.
Influences on Satisfaction. Odds ratios demonstrating the influence of selected
organizational, provider, and patient characteristics on different types of patient
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satisfaction are depicted in Table 5. None of the factors tested influenced the odds that
Black women would report high levels of general satisfaction. Respondents who recently
experienced a FPM result were 66% less likely to be satisfied with the convenience and
accessibility of mammography services. Women with recent FPM results were also 58%
less likely to be satisfied with the way providers communicated these results to them.
Reduced satisfaction with provider information given was also shared by women with
family history of BRCA (64% less) and those experiencing discrimination (68% less)
during their most recent mammography encounter. As with general satisfaction, provider
interpersonal style was not influenced by any of the characteristics collected.
Multiple factors were found to impact patient perceptions of providers’ technical
expertise. Facility characteristics such as serving an older population, having more
screening hours, and providers reporting a higher perception of patients' physical
discomfort were associated with lower levels of satisfaction with providers' skills.
Conversely, the presence of educational materials, higher perceptions of patient distress
due to mammography, and being asked to complete mammography follow-up was
associated with increased satisfaction with providers' expertise. Similar characteristics
influenced women's satisfaction with the physical environment, with the presence of
educational materials increasing satisfaction and higher screening hours and an older
patient population linked to reduced satisfaction.
Discussion
The experience of receiving a FPM result may have an immediate and long lasting
impact on Black women’s BRCA screening experiences, especially as it relates to their
satisfaction with the clinical encounter. We examined multilevel influences on
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mammography satisfaction among Black women receiving FPM results and generated
mixed findings. First, we sought to determine if satisfaction levels differed by facility.
Despite the varied characteristics of the mammography facilities assessed, no site-level
differences in patient satisfaction were detected in this group of Black women. While it is
possible that the sample size limited our ability to detect site-level differences, it is much
more likely that standardization of patient notification and care procedures in this health
system resulted in women having similar experiences across clinical sites.
Next, we investigated the relationship between the various types of satisfaction and
facility, provider, and patient characteristics. No influences on general satisfaction or
satisfaction with provider interpersonal style were detected in this sample. Survey items
in both subscales were very non-specific, (e.g. I was very satisfied with the care I
received at the service; The staff had good manners.) thus there was no obvious
connection between the domains and the factors tested.
Multiple factors were found to be related to satisfaction with the convenience of
mammography. As expected, FPM status was associated with low satisfaction with
convenience, which is mostly likely a result of the challenges related to completing
additional procedures.14,17 Surprisingly women with a family history of BRCA were also
less likely to be satisfied with the convenience of mammography. The most probable
explanation is that these women were asked to complete additional tests due to their
increased BRCA risk, thus complicating their screening encounter. Experiencing
discrimination also resulted in lower satisfaction with mammography convenience,
paralleling findings linking mistrust to lower levels of mammography satisfaction in
Black women.20 Evidence demonstrates that experiencing racial discrimination during

72

healthcare interactions is strongly associated with postponing/not accessing healthcare.30
It is not unreasonable to conclude that Black women’s perceptions of convenience in
accessing health services could be affected by perceived discrimination.
Women’s satisfaction with providers’ ability to provide information during the
screening process was negatively associated with FPM status. Multiple studies have
reported that Black women are more likely to have inadequate or incomplete
communication around abnormal mammography results.6,14,17,18,31 Communication needs
for this group include: a preference for results delivered over the phone vs. the mail,
definitions of terms used to explain results, and a more detailed description of the
activities involved in mammography follow up.6,17,32 Actions to improve communication
of mammography results should address cultural differences in communication in
addition to implicit biases that may lead to perceptions of racial discrimination.33–35
Similar factors appear to be related to perceptions of provider expertise as satisfaction
with provider competence was positively associated with providers’ reporting higher
levels of patient psychological distress and the presence of educational materials. Serving
an older patient population, a higher number of weekly screening hours, and providers’
perception of a high level of physical discomfort on the part of patients was associated
with lower levels of satisfaction with provider competence. Satisfaction with the clinical
environment was influenced by the same facility features in the same directions. It is not
exactly clear how these factors contribute to reduced satisfaction; one possibility is that
both factors may lead to the perception of slower service in the waiting room and/or more
hesitation on the part of the provider during the clinical encounter.
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Our study has some limitations. Due to the small sample size, it was not possible to
examine relevant characteristics for all three levels in one model. It is possible that some
organization level effects may disappear in the presence of patient-level effects and vice
versa. Additionally, certain patient-level factors that may influence satisfaction including
patient health status and pain/discomfort felt during the clinical exam were not evaluated.
Another point of consideration is the data for this study comes from multiple sites within
a single hospital system. Examining satisfaction across multiple hospital systems might
reveal additional influences on satisfaction due to the lack of standardization in
procedures. Lastly, this study examined different categories of factors that affect patient
satisfaction, but it did not link satisfaction to mammography follow-up times, follow up
intention, or the completion of future follow-up procedures. Studies should be developed
to allow for the examination of multilevel influences concurrently, that include additional
influences on satisfaction at each level, span multiple health systems, and/or link
satisfaction to mammography follow-up outcomes.
Despite these limitations, we concluded that specific domains of Black women’s
satisfaction with the mammography process are influenced by different categories of
factors. Satisfaction with convenience and provider information transfer were largely
impacted by individual experiences such as FPM status or family history, while
satisfaction with provider competence and the facility environment were shaped by a
combination of provider and facility-related factors. More attention needs to be paid to
the aspects of the clinical encounter that shape Black women's experiences to determine
how to structure healthcare services with the goal of reducing racial inequities in cancer
burden.

74

References
1.

2.

3.

4.

5.

6.

7.
8.
9.

10.

11.

12.

13.

14.

15.

DeSantis CE, Siegel RL, Sauer AG, Miller KD, Fedewa SA, Alcaraz KI, et al.
Cancer statistics for African Americans, 2016: Progress and opportunities in
reducing racial disparities: Cancer Statistics for African Americans, 2016. CA
Cancer J Clin. 2016 Jul;66(4):290–308.
Schueler K, Chu P, Smith-Bindman R. Factors associated with mammography
utilization: a systematic quantitative review of the literature. J Womens Health
15409996. 2008 Nov;17(9):1477–98.
Adams SA, Smith ER, Hardin J, Prabhu-Das I, Fulton J, Hebert JR. Racial
differences in follow-up of abnormal mammography findings among economically
disadvantaged women. Cancer. 2009 Dec 15;115(24):5788–97.
Jones CE, Maben J, Jack RH, Davies EA, Forbes LJ, Lucas G, et al. A systematic
review of barriers to early presentation and diagnosis with breast cancer among
Black women. BMJ Open. 2014 Feb 1;4(2):e004076.
Kerner JF, Yedidia M, Padgett D, Muth B, Washington KS, Tefft M, et al. Realizing
the promise of breast cancer screening: Clinical follow-up after abnormal screening
among Black women. Prev Med. 2003 Aug;37(2):92–101.
Padgett DK, Yedidia MJ, Kerner J, Mandelblatt J. The emotional consequences of
false positive mammography: African-American women’s reactions in their own
words. Women Health. 2001 Aug 21;33(3–4):1–15.
Brewer NT, Salz T, Lillie SE. Systematic review: the long-term effects of falsepositive mammograms. Ann Intern Med. 2007;146(7):502–510.
Rimer BK, Bluman LG. The psychosocial consequences of mammography. JNCI
Monogr. 1997;1997(22):131–138.
Somkin CP, McPhee SJ, Nguyen T, Stewart S, Shema SJ, Nguyen B, et al. The
effect of access and satisfaction on regular mammogram and Papanicolaou Test
screening in a multiethnic population. Med Care. 2004 Sep;42(9):914–26.
Gierisch JM, Earp JA, Brewer NT, Rimer BK. Longitudinal predictors of
nonadherence to maintenance of mammography. Cancer Epidemiol Biomarkers
Prev. 2010 Apr 1;19(4):1103–11.
Drossaert CHC, Boer H, Seydel ER. Monitoring women’s experiences during three
rounds of breast cancer screening: results from a longitudinal study. J Med Screen.
2002;9(4):168–175.
Brett J, Austoker J. Women who are recalled for further investigation for breast
screening: psychological consequences 3 years after recall and factors affecting re‐
attendance. J Public Health. 2001 Dec 1;23(4):292–300.
Dolan NC, Feinglass J, Priyanath A, Haviley C, Sorensen AV, Venta LA. Measuring
satisfaction with mammography results reporting. J Gen Intern Med.
2001;16(3):157–62.
Allen JD, Shelton RC, Harden E, Goldman RE. Follow-up of abnormal screening
mammograms among low-income ethnically diverse women: Findings from a
qualitative study. Patient Educ Couns. 2008 Aug;72(2):283–92.
Schutt RK, Cruz ER, Woodford ML. Client Satisfaction in a Breast and Cervical
Cancer Early Detection Program: The Influence of Ethnicity and Language, Health,
Resources, and Barriers. Women Health. 2008 Nov 25;48(3):283–302.

75

16. Løken K, Steine S, L\a erum E. Mammography: influence of departmental practice
and women’s characteristics on patient satisfaction: comparison of six departments
in Norway. Qual Health Care. 1998;7(3):136–141.
17. Engelman KK, Cizik AM, Ellerbeck EF. Women’s satisfaction with their
mammography experience: Results of a qualitative study. Women Health.
2005;42(4):17–35.
18. Clark S, Reeves PJ. Women’s experiences of mammography: A thematic evaluation
of the literature. Radiography. 2015 Feb;21(1):84–8.
19. Doyle CA, Stanton MT. Significant factors in patient satisfaction ratings of
screening mammography. Radiography. 2002 Aug;8(3):159–72.
20. Molina Y, Kim S, Berrios N, Calhoun EA. Medical mistrust and patient satisfaction
with mammography: the mediating effects of perceived self-efficacy among
navigated African American women. Health Expect. 2015 Dec;18(6):2941–50.
21. Ferrante JM, Chen P-H, Kim S. The effect of patient navigation on time to diagnosis,
anxiety, and satisfaction in urban minority women with abnormal mammograms: A
randomized controlled trial. J Urban Health. 2008 Jan;85(1):114–24.
22. Nutting PA, Baier M, Werner JJ, Cutter G, Conry C, Stewart L. Competing demands
in the office visit: what influences mammography recommendations? J Am Board
Fam Pract. 2001 Sep 1;14(5):352–61.
23. National Center for Health Statistics (U.S.). Design and estimation for the National
Health Interview Survey, 1995-2004. Hyattsville, Md.: U.S. Dept. of Health and
Human Services, Centers for Disease Control and Prevention, National Center for
Health Statistics; 2000.
24. Ingram D, Franco S. NCHS urban-rural classification scheme for counties. Vital
Health Stat 2. 2012 Jan;(154):1–65.
25. South Carolina Department of Health and Human Services. South Carolina
Department of Health and Human Services [Internet]. 2017 [cited 2017 Apr 8].
Available from: https://www.scdhhs.gov/
26. National Committee for Quality Assurance. NCQA Health Insurance Plan Ratings
2016-2017 [Internet]. 2017 [cited 2017 Apr 8]. Available from:
http://healthinsuranceratings.ncqa.org/2016/Default.aspx
27. Stewart AL, Nápoles-Springer AM, Gregorich SE, Santoyo-Olsson J. Interpersonal
Processes of Care Survey: Patient-reported measures for diverse groups. Health Serv
Res. 2007 Jun;42(3 Pt 1):1235–56.
28. Cockburn J, Hill D, Irwig L, De Luise T, Turnbull D, Schofield P. Development and
validation of an instrument to measure satisfaction of participants at breast screening
programmes. Eur J Cancer Clin Oncol. 1991 Jul;27(7):827–31.
29. StataCorp. Stata Statistical Software: Release 13. College Station, TX: StataCorp
LP; 2013.
30. Lee C, Ayers SL, Kronenfeld JJ. The association between perceived provider
discrimination, health care utilization, and health status in racial and ethnic
minorities. Ethn Dis. 2009;19(3):330.
31. Jones BA, Reams K, Calvocoressi L, Dailey A, Kasl SV, Liston NM. Adequacy of
Communicating Results From Screening Mammograms to African American and
White Women. Am J Public Health. 2007 Mar;97(3):531–8.

76

32. Marcus EN, Drummond D, Dietz N. Urban women’s preferences for learning of
their mammogram result: a qualitative study. J Cancer Educ. 2012 Mar;27(1):156–
64.
33. Cooper LA, Beach MC, Johnson RL, Inui TS. Delving below the surface. J Gen
Intern Med. 2006 Jan;21(Suppl 1):S21–7.
34. Shirazi M, Engelman KK, Mbah O, Shirazi A, Robbins I, Bowie J, et al. Targeting
and tailoring health communications in breast screening interventions. Prog
Community Health Partnersh Res Educ Action. 2015;9(2):83–89.
35. Hall MB, Carter-Francique AR, Lloyd SM, Eden TM, Zuniga AV, Guidry JJ, et al.
Bias Within: Examining the role of cultural competence perceptions in
mammography adherence. SAGE Open. 2015;5(1):2158244015576547.

77

Table 4.1 Mammography Facility Characteristics by Site
Site A
f
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Screening Patient Demographics
Age Range
40-49
50-64
65+
Race/Ethnicity
White
Black
Latina
Other
Geographic Location
Rural
Urban
Health Insurance Type
Private
Public
Uninsured
Physical Characteristics
# of Waiting Rooms
# of Exam Rooms
Educational materials? Y/N
Utilization Characteristics
Procedures
Screening Visits
Diagnostic Visits
Weekly
Operating Hours
Screening
Diagnostic

Site B
%

f

Site C
%

F

Site D
%

Site E

f

%

f

%

1,951
4,699
4,234

17.9
43.2
38.9

1,155
2,455
1,690

21.8
46.3
31.9

734
1,548
1,408

19.9
42.0
38.2

247
605
513

18.1
44.3
37.6

513
942
291

29.4
54.0
16.6

5,881
4,620
133
250

54.0
42.5
1.2
2.3

2,028
3,050
64
158

38.3
57.6
1.2
3.0

2,786
733
23
148

75.5
19.9
0.6
4.0

652
621
15
77

47.8
45.5
1.1
5.7

1,099
523
14
110

62.9
30.0
0.8
5.7

386
10,326

3.6
96.4

191
5,031

3.7
96.3

245
3,409

6.7
93.3

5
1,349

0.4
99.6

266
1,447

15.5
84.5

5,368
5,269
243

49.3
48.4
2.2

2,561
2,610
124

48.4
49.3
2.3

1,981
1,695
14

53.7
45.9
0.4

689
639
12

51.4
47.7
0.9

1,283
450
13

73.5
25.8
0.7

4
15
No

10,939
1,781

3
14
Yes

86.0
14.0

47.5
31.5

*Bolded values are statistical significant at the p<0.05 level

5,325
764

40
35

1
4
No

87.4
27.3

3,700
257

50
14

1
1
No

93.5
9.2

1,371
0

42
0

1
3
No

100.0
0

1,750
0

42
0

100.0
0

Table 4.2 Provider Perceptions of Patient Screening Experiences by Site n =24*
Characteristics
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a
c

Site A

Site B

Site C

Site D

f

Mean (Std)

f

Mean (Std)

f

Mean
(Std)

f

Mean (Std)

How much physical discomfort do women
experience during a mammogram?a

10

2.7 (0.95)

12

2.4 (1.00)

8

3.0 (0.93)

2

3.5 (0.71)

How much psychological distress do women
experience during a mammogram?b

10

2.4 (0.70)

12

2.5 (0.80)

8

2.5 (0.76)

2

2.0 (0.00)

How often are women upset by this
experience (getting called back for follow up
testing)?c

10

3.1 (0.88)

12

3.7 (0.89)

8

3.9 (0.35)

2

3.5 (0.71)

How often are Black women upset by this
experience (getting called back for follow up
testing)?c

10

3.0 (0.82)

12

3.33 (0.89)

8

3.6 (0.52)

2

3 (1.41)

Responses range from 1= No discomfort to 5 = A great deal of discomfort; b Responses range from 1= No distress to 5 = A great deal of distress;
Responses options: 1= Never, 2 = Seldom, 3 = About half the time, 4 = Usually, 5 = Always; *Bolded values are statistical significant at the p<0.05 level

Table 4.3 Demographic and Screening Characteristics of Patient Survey Respondents n =117
F
% or
Mean (Std)
Race
Black/African American
117
100.0
Age Range
40-49
22
18.8
50-64
63
53.9
65+
32
27.3
Marital Status
Married
35
29.9
Living with a partner
3
2.6
Widowed
22
18.8
Divorced
33
28.2
Separated
6
5.1
Single/Never Married
18
15.4
Geographic Location
Urban
114
97.4
Education
High school or less
83
70.9
College or more
34
29.1
Income
Less than 50K
82
75.2
50K or more
27
24.8
Health Insurance Type
Private
53
45.3
Public
60
51.3
Uninsured
4
3.4
Family History of Breast Cancer - Yes
35
29.9
% With False Positive Mammograms
54
46.1
Screening Site
A
54
46.1
B
35
29.9
C
7
6.0
D
16
13.7
E
5
4.3
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Table 4.4 Patient Survey Respondents’ Mammography Satisfaction and Communication Scores by Site n
=117
Site A
Mean (Std)
n = 51
Mammography Satisfaction
General
(Range: 13-22)
Convenience and Accessibility
(Range: 12-18)
Provider Information
(Range: 8-17)
Provider Interpersonal Style
(Range: 8-17)
Provider Competence
(Range: 8-17)
Physical Environment
(Range: 13-22)
Provider Communication
Discrimination
(Range: 1-4)
Disrespectful Office Staff
(Range: 1-4)
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Site B
Mean
(Std)
n = 32

Site C
Mean
(Std)
n=7

Site D
Mean
(Std)
n = 16

Site E
Mean
(Std)
n=5

17.7
(2.6)
14.5
(1.4)
14.5
(4.5)
14.6
(1.5)
14.2
(1.8)
16.9
(2.2)

18.2
(2.2)
14.6
(1.7)
14.2
(2.1)
14.9
(1.6)
14.9
(1.6)
18.1
(2.2)

18.6
(1.9)
14.7
(1.5)
15.0
(1.7)
15.1
(1.5)
15.1
(1.5)
17.6
(2.5)

17.9
(2.0)
13.8
(2.4)
13.8
(1.9)
14.3
(2.1)
14.1
(2.1)
16.9
(2.4)

18.8
(1.1)
14.6
(1.5)
14.2
(2.0)
14.4
(2.2)
14.0
(1.9)
17.2
(2.3)

1.1
(0.3)
1.1
(0.2)

1.1
(0.3)
1.1 (0.2)

1
(0)
1
(0)

1.3
(0.5)
1.1
(0.3)

1.2
(0.3)
1
(0)
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Table 4.5. Bivariable Logit Models Describing Associations with High Levels of Mammography Satisfaction Among Black Women*
General
Convenience
Provider
Provider
Provider
Physical
Information
Interpersonal
Competence
Environment
Communicatio
Style
n
OR (CI)
OR (CI)
OR (CI)
OR (CI)
OR (CI)
OR (CI)
Facility Factors
Patient age: 50+
0.72 (0.31-1.69)
0.62 (0.27-1.40) 0.63 (0.28-1.41) 0.57 (0.24-1.32) 0.35 (0.15-0.84) 0.39 (0.17-0.89)
Patient age: 40-49
1.00
1.00
1.00
1.00
1.00
1.00
Patient race:
Majority Non-White
0.34 (0.06-1.80)
0.77 (0.20-2.92) 0.54 (0.13-2.13) 0.68 (0.15-2.98) 0.91 (0.21-3.82) 2.26 (0.60-8.48)
Patient race:
Majority White
1.00
1.00
1.00
1.00
1.00
1.00
Patient insurance status:
High % Non-Private
2.57 (0.51-12.70) 1.27 (0.35-4.55) 2.29 (0.61-8.58) 1.87 (0.46-7.57) 1.37 (0.37-4.99) 0.77 (0.22-2.70)
Patient insurance status:
Low % Non-Private
1.00
1.00
1.00
1.00
1.00
1.00
# of Waiting rooms: High
0.78 (0.30-2.02)
1.22 (0.50-2.97) 0.72 (0.30-1.76) 0.78 (0.31-1.96) 0.92 (0.38-2.22) 0.97 (0.40-2.31)
# of Waiting rooms: Low
1.00
1.00
1.00
1.00
1.00
1.00
# of Exam rooms: High
0.78 (0.30-2.02)
1.22 (0.50-2.97) 0.72 (0.30-1.76) 0.78 (0.31-1.96) 0.92 (0.38-2.22) 0.97 (0.40-2.31)
# of Exam rooms: Low
1.00
1.00
1.00
1.00
1.00
1.00
# of Education materials: Present
1.02 (0.43-2.40)
1.56 (0.67-3.63) 1.49 (0.65-3.41) 1.89 (0.78-4.59) 3.04 (1.22-7.57) 2.95 (1.12-6.93)
# of Education materials: Absent
1.00
1.00
1.00
1.00
1.00
1.00
Patient volume: High
0.78 (0.30-2.02)
1.22 (0.50-2.97) 0.72 (0.30-1.76) 0.78 (0.31-1.96) 0.92 (0.38-2.22) 0.97 (0.40-2.31)
Patient volume: Low
1.00
1.00
1.00
1.00
1.00
1.00
Screening hours: High
0.87 (0.39-1.91)
0.86 (0.40-1.85) 0.71 (0.33-1.51) 0.64 (0.29-1.39) 0.45 (0.20-0.97) 0.38 (0.17-0.82)
Screening hours: Low
1.00
1.00
1.00
1.00
1.00
1.00
Diagnostic hours: High
0.78 (0.30-2.02)
1.22 (0.50-2.97) 0.72 (0.30-1.76) 0.78 (0.31-1.96) 0.92 (0.38-2.22) 0.97 (0.40-2.31)
Diagnostic hours: Low
1.00
1.00
1.00
1.00
1.00
1.00
Provider Factors
Perception of patient discomfort:
High
0.88 (0.37-2.08)
N/A
0.64 (0.28-1.48) 0.53 (0.21-1.29) 0.32 (0.12-0.81) N/A
Perception of patient discomfort:
Low
1.00
1.00
1.00
1.00
1.00
1.00
Perception of patient distress:
High
1.07 (0.48-2.38)
N/A
1.74 (0.80-3.79) 2.08 (0.93-4.66) 2.65 (1.19-5.92) N/A
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Perception of patient distress:
Low
1.00
1.00
Perception patient upset by
follow up: High
1.07 (0.48-2.38)
N/A
Perception patient upset by
follow up: Low
1.00
1.00
Perception Black patient upset
by follow up: High
1.21 (0.53-2.77)
N/A
Perception Black patient upset
by follow up: Low
1.00
1.00
Patient Factors
FPM Results
0.73 (0.33-1.60)
0.34 (0.16-0.73)
Normal Results
1.00
1.00
Age Range
40-49
1.00
1.00
50-64
1.01(0.35-2.91)
1.12 (0.40-3.11)
65+
0.84 (0.26-2.072) 1.09 (0.72-5.31)
Partnered
0.60 (0.26-1.35)
1.17 (0.52-2.64)
Unpartnered
1.00
1.00
High school or less
0.81 (0.33-1.96)
0.84 (0.36-1.96)
College graduate or more
1.00
1.00
Less than 50K
0.67 (0.25-1.78)
0.68 (0.27-1.72)
More than 50K
1.00
1.00
Private health insurance
0.91 (0.08-9.58)
0.88 (0.41-1.90)
Public health insurance
1.00
1.00
Family History of BRCA
0.58 (0.25-1.33)
0.35 (0.15-0.82)
No Family History of BRCA
1.00
1.00
High Discrimination Score
0.59 (0.23-1.51)
0.32 (0.12-0.87)
Low Discrimination Score
1.00
1.00
High Disrespectful Office Staff
Score
0.56 (0.18-1.77)
0.99 (0.30-3.19)
Low Disrespectful Office Staff
Score
1.00
1.00
*Bolded values are statistical significant at the p<0.05 level

1.00

1.00

1.00

1.00

1.74 (0.80-3.79)

2.08 (0.93-4.66)

2.65 (1.19-5.92)

N/A

1.00

1.00

1.00

1.00

1.94 (0.86-4.36)

2.40 (1.00-5.72)

1.94 (0.86-4.36)

N/A

1.00

1.00

1.00

1.00

0.42 (0.20-0.89)
1.00

0.62 (0.29-1.34)
1.00

0.58 (0.27-1.22)
1.00

0.52 (0.24-1.08)
1.00

1.00
0.96 (0.35-2.67)
0.54 (0.17-1.69)
1.60 (0.71-3.60)
1.00
0.62 (0.26-1.45)
1.00
0.67 (0.27-1.64)
1.00
0.61 (0.05-6.63)
1.00
0.72 (0.32-1.63)
1.00
0.47 (0.18-1.22)
1.00

1.00
0.88 (0.31-2.48)
1.16 (0.36-1.83)
0.76 (0.34-1.72)
1.00
0.76 (0.32-1.82)
1.00
0.90 (0.36-2.28)
1.00
0.56 (0.05-5.87)
1.00
0.51 (0.22-1.16)
1.00
0.38 (0.15-0.96)
1.00

1.00
0.39(0.13-1.17)
0.55 (0.16-2.60)
0.52 (0.23-1.17)
1.00
1.01 (0.44-2.32)
1.00
1.60 (0.66-3.88)
1.00
0.48 (0.04-5.10)
1.00
0.67 (0.30-1.52)
1.00
0.39 (0.15-1.00)
1.00

1.00
0.77 (0.28-2.12)
0.64 (0.21-1.98)
1.12 (0.51-2.47)
1.00
0.80 (0.35-1.82)
1.00
0.74 (0.30-1.81)
1.00
0.46 (0.04-4.87)
1.00
0.51 (0.22-1.15)
1.00
0.53 (0.20-1.36)
1.00

0.57 (0.18-1.81)

0.47 (0.15-1.49)

0.82 (0.26-2.58)

0.46 (0.14-1.50)

1.00

1.00

1.00

1.00

4.2 False-Positive Mammography and Mammography Screening Intentions Among
Black Women: The Influence of Emotions and Coping Strategies1

1

Farr DE, Brandt HM, Friedman DB, Armstead C, Adams SA, Fulton J, Bull D. To be
submitted to American Journal of Preventive Medicine
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Abstract
Abnormal mammograms confirmed as benign are known as false-positive
mammography (FPM) results. Research indicates that a history of FPM results may be
linked to mammography follow-up delays in Black women, yet much of the research on
FPM has focused on White women. The purpose of this study was to examine the
influence of FPM on breast cancer (BrCa) screening beliefs and intentions in Black
women. BrCa-free, Black women, aged 40 and older who completed screening
mammograms in 2016 were recruited for a case-control study. Print surveys assessing
demographics, anxious personality, general anxiety, BrCa-specific anxiety, depression,
BrCa screening history, BrCa beliefs, and Afrocentric coping behaviors were mailed to
participants. Women with FPM results were cases, and women with normal results
screened on the same day served as matched controls. The final sample consisted of 117
respondents (54 cases, 63 controls). Ordinary least squares (OLS) models were
constructed. Personality traits, emotional states, and coping behaviors were tested as
mediators and moderators of the relationship between FPM results and BrCa beliefs.
FPM status was associated with a higher perception of barriers to mammography and
perceived barriers were associated with a lower intention to complete mammography.
Afrocentric coping behaviors moderated the perception of mammography barriers for
women with FPM results. FPM status had a detrimental impact on BrCa beliefs in Black
women, but the use of collective coping behaviors weakened this relationship. Culturally
specific research focused on Black women is needed to explore influences on BrCa
screening beliefs and mammography completion in this population.
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Introduction
Despite a continuous decrease in breast cancer (BrCa) mortality among American
women, racial inequities in BrCa mortality have remained constant.1 An important driver
of these inequities among Black women is their increased rate of advanced staged tumors
at diagnosis, which is partially due to delays in mammography screening resolution.2–6
Delayed mammography follow-up in Black women has been attributed to various social,
cultural, and socioeconomic factors, but the influence of Black women’s prior healthcare
experiences, such as receiving a false-positive mammography (FPM) result has not been
fully explored.7–9
FPM results are abnormal screening mammograms that are determined to be nonmalignant after diagnostic testing.10–12 Clinically, FPM results correspond to a Breast
Imaging Reporting and Data System (B-IRADS) classification of 0 (Incomplete additional imaging evaluation and/or comparison to prior mammograms in needed), 3
(Probably benign finding), 4 (Suspicious abnormality) or 5 (Highly suggestive of
malignancy).13 Normal mammograms are classified as BI-RADS 1 or 2.13 Anywhere
from 5-10% of mammograms each year result in a FPM, but cumulatively, a woman has
a 41.6-61.3% chance of receiving a FPM result during her screening life depending on
the age at which she initiates screening (anytime between 40 and 50 years of age) and her
screening schedule (annual vs. biennial).10,14–17 FPM may lead to potentially negative
outcomes, such as additional financial costs due to follow-up testing, impaired daily
function, negative emotional states, and decreased BrCa screening intentions and
behaviors.10,18
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Recent systematic reviews report that despite experiencing general and BrCa
specific anxiety after receiving a FPM, American women are more likely to complete
screening mammograms than their European and Canadian counterparts.10,18 Very few
studies of FPM assess BrCa screening beliefs or integrate health behavior theory, so the
exact mechanism that links FPM results with increased mammography completion is
unknown. Furthermore, these findings may not apply to Black women as they have not be
included in sufficient numbers or a part of subgroup analyses in studies of this
topic.10,16,17,19–23
A handful of studies have examined FPM outcomes in women of color, but these
studies mainly compared the emotional states of White women to heterogenous groups of
women of color.24,25 As a result, these studies have produced inconsistent findings
regarding the effects of FPM results non-White women.24,25 The only study to compare
Black women with FPM to those with normal results found that FPM status was
associated with higher levels of worthlessness and restlessness.26
Black women’s experiences with and reactions to FPM may be an important
aspect of their screening experience. One qualitative study of Black BrCa survivors
presented accounts of women who delayed seeking care for lumps due to past FPM.27 In
another study by Kerner et al., Black women who completed mammography follow-up
after the 90-day window were more likely to have had an abnormal mammogram in the
past and displayed higher levels of anxiety than Black women with normal results.28
Together these findings imply a potential link between prior FPM and mammography
delay in Black women.
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Racial differences are not limited to influences on screening behaviors, but also
extend to the impact of coping strategies. In general, coping behaviors vary across
racial/ethnic groups and in response to different events, necessitating the use of culturally
specific assessments to adequately describe these behaviors.29,30 A study of FPM results
and coping behaviors found that Latinas engaged in more avoidant and religious coping
which led to higher levels of distress than their White counterparts.31 Racial variation in
screening and coping outcomes of FPM results underscores the need for studies that
focus on Black women to develop contextually relevant theories and knowledge about
screening influences in this population.32
The goal of this study was to examine the influence of FPM results on
mammography beliefs among Black women. Components of the transactional model of
stress and coping and the health belief model guided the data collection and analysis for
this study.33,34 A FPM result can be conceptualized as a stressful event which leads to
concurrent primary and secondary appraisals.33 Primary appraisals generate emotional
responses, while secondary appraisals lead to a course of action which may include
coping responses.33,35 BrCa screening beliefs, specifically influential predictors of
mammography behaviors such as the Health Belief Models’ perceived benefits and
perceived barriers constructs, can be influenced by women’s coping responses.33,35,36
Personality traits, cultural differences in social contexts, and emotional expression can
also impact appraisal and the relationship between health beliefs and behaviors.35–37 The
variability of these characteristics across racial/ethnic groups may generate different FPM
responses and outcomes by group.
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We (the authors) hypothesized that FPM results will adversely effect BrCa
screening beliefs. As part of the appraisal process, emotions will mediate the relationship
between BrCa beliefs and FPM status. Personality traits and coping behaviors will
moderate these relationships. FPM status will have detrimental effects on mammography
intention as will high levels of perceived susceptibility to BrCa, high levels of perceived
mammography barriers, and low levels of perceived mammography benefits.
Methods
Setting. This study was conducted in collaboration with a leading provider of
mammography services in Richland County, South Carolina.2 Richland County is an area
where 46% of the population was classified as African American/Black.38 Study activities
were approved by the Palmetto Health Institutional Review Board.
Study design. Preliminary estimates indicated FPM results represented 6% of
screening mammograms performed at the participating health system during any 12month period. A case-control study design was implemented given the rarity of FPM
results in a single year. Eligible participants were selected from records of women
completing screening mammograms at eligible facilities between January and August
2016. Black women aged 40 and older, BrCa free for five years or more, no indication of
major mental illness, and whose final mammography results were confirmed as benign
were eligible to participate. Women whose screening mammograms were classified as
BI-RADS Category 0 were selected as cases.13 One control participant was selected from
eligible women who completed screening on the same day and at the same facility, but
had normal results (BI-RADS Category 1 or 2).13 Packets containing surveys, postage
paid return envelopes, and medical records release forms were mailed to potential
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participants five to six months after their initial screening mammograms to allow for
screening resolution (June 2016-January 2017). Reminder letters were sent to nonresponders one month after the initial mailing and prior to the end of the study. Medical
records were used to confirm BrCa screening history information reported via survey.
Measures. Patient age, zip code, health insurance information, and screening
facility were obtained from patient medical records. Patient zip codes were matched to
counties, and the National Center for Health Statistics Urban-Rural Classification
Scheme for counties was used to classify areas as urban or rural.39 The South Carolina
Department of Health and Human Services website and the National Committee for
Quality Assurance Health Insurance Plan Ratings 2016-2017 were used to identify
insurance products, which were further collapsed into three categories: private, public,
and uninsured.40,41 Survey questions assessing patient education, family history of
BRCA, and age at first mammogram were modeled after items on the National Health
Interview Survey.42
BrCa beliefs were measured using the Champion Attitudes Towards
Mammography and Breast Cancer Scale, an assessment of the health belief model which
was developed using Black women.43 The Perceived Benefits, Perceived Susceptibility,
and a shortened 10-item version of the Perceived Barriers subscale were included in this
study.43 All three subscales displayed high internal consistency in this sample with α=
0.70, 0.84, and 0.85, respectively. Intention to complete future screening mammograms
and follow-up tests were each assessed with a single item: 1) How likely are you get your
next screening mammogram as scheduled? and 2) If you asked to return for follow-up
testing after your next screening mammogram, how likely are you to complete those
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additional tests? Response categories were 1=Very Unlikely, 2=Unlikely, 3=Likely, and
4=Very Likely.
Anxious personality and general anxiety were measured using the 10-item short
forms of the Spielberger State-Trait Anxiety Inventory (STAI) Trait and State Anxiety
Scales.44 A six-item anxiety subscale of the Psychological Consequences Questionnaire
DK-33 (PCQ-DK33) was used to assess BrCa-specific anxiety and displayed high
reliability in this population (α= 0.93).45 Depression was assessed with the Center for
Epidemiologic Studies Depression Scale Short Form (CES-D 10).46,47
The Africultural Coping Systems Inventory (ACSI) measures coping behaviors
used by Black Americans and contains four subscales: cognitive/emotional debriefing,
collective, spiritual-centered, and ritual centered.48 Reliability coefficients for the four
ACSI subscales in the current sample ranged 0.78 to 0.89.
Statistical analysis. Analyses were conducted in STATA 13.49 Chi-square tests
were employed to examine demographic differences between case and control
participants. T-tests and ANOVA were used to examine differences in BrCa beliefs and
psychosocial factors. Study hypotheses were tested using OLS models. Variables with
theoretical relationships to the outcome of interest were included in the models. Missing
observations were removed from models via case-wise deletion. The ‘khb command’ in
STATA (Sobel test) was used to test for mediation. Continuous variables were centered
at the mean value for the overall sample. Separate models with interaction terms
combining the main independent variable (FPM status) with anxious personality, anxiety,
depression and coping behaviors were created to determine the influence of these
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characteristics on the main outcome variables (BrCa beliefs). An alpha of 0.05 was used
to determine statistical significance in all models.
Results
Between January and August 2016, 9,826 Black women completed screening
mammograms and were eligible for study participation. In total, 909 survey packets were
mailed (411 cases, 498 controls), 25 surveys were returned to sender, and two recipients
reported ineligibility and did not return surveys. Of the remaining 882 surveys
distributed, 133 (15.0%) were returned. Five survey participants were found to be
ineligible due to recent BrCa diagnoses or mental illness. Another 11 were excluded from
analyses due to missing information or conflicting responses. The final analytic sample
consists of 54 case and 63 control participants for a total of 117 respondents. Most of the
survey respondents were aged 50 and older, had at least a high school education, and had
health insurance coverage. Table 1 displays demographic, BrCa screening, and
psychosocial information for both groups. Case and control respondents were similar on
demographic variables, but significant differences were detected in the mammography
barriers scores. Women with FPM results reported an increased perception of barriers
compared to women with normal results (13.8 vs. 12.2, p=0.04). Additionally, women
with FPM results displayed more general and BrCa-specific anxiety compared to women
without FPM results. Both groups of women reported using similar coping styles, except
for cognitive/emotional coping behaviors which were more prevalent among women with
FPM results.
Multiple OLS models were constructed to investigate the influence of FPM
results on BrCa screening beliefs (Table 2). Only the models describing perceived
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susceptibility to BrCa (R2 =0.22, p=0.00) and the perceived barriers to mammography
(R2=0.19, p=0.00) were statistically significant. Receipt of FPM results was associated
with a higher perceived barriers score. Anxious personality, anxiety, depression, and
coping strategies were tested as mediators, but none of these variables explained this
relationship. Testing for effect moderation revealed that the use of collective coping
behaviors was associated with a lower mean perceived barriers score among women with
FPM results (Figure 1.)
Separate models describing the screening and follow-up testing intentions were
constructed (Table 3.) Perceived benefits of mammography were not included in BrCa
screening and diagnostic intention models being that the base model was not statistically
significant. Neither type of intention was influenced by perceived BrCa susceptibility
(R2=0.09, p=0.53; R2=0.10, p=0.40 for screening and follow up intention respectively).
Both intentions to complete screening mammography (R2=0.21, p=0.00) and diagnostic
testing (R2=0.31, p=0.00) were inversely associated with the perceived barriers score.
Discussion
Previously unasked questions about the relationship between FPM, BrCa
screening beliefs, and mammography intentions in a sample of Black women were
explored in this study. We hypothesized that FPM status would lead to lower levels of
perceived mammography benefits, higher levels of perceived susceptibility to BrCa, and
perceived barriers to mammography. In our sample, FPM status was not associated with
the perception of the benefits of mammography nor perceived susceptibility to BrCa.
Previous studies consistently reported elevated mammography benefits and BrCa
susceptibility scores among White women with FPM results.10,18 While the perception of
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benefits has not been shown to impact mammography adherence, regardless of race,
BrCa susceptibility has been linked to increased motivation to complete mammography
among White women.10 Research on perceived susceptibility to BrCa suggests that Black
women perceive lower levels of BrCa risk and that perceived susceptibility has no
influence on their BrCa screening behavior.37,50 Our findings regarding perceived
susceptibility corresponds with the literature describing BrCa screening beliefs among
Black women in general.
In our study, FPM status was associated with an increased perception of barriers
to mammography, which conflict with DeFrank et al.’s findings of no relationship
between these factors.16 This difference is likely due to the fact that we used the
Champion barrier items which assessed logistical, psychosocial, and financial concerns,
while DeFrank et al. only examined financial barriers to mammography completion.16,43
It is not surprising that women with FPM status reported more barriers given their
experience with the various challenges associated with the completion of follow up
testing.
We also hypothesized that anxiety and depression would mediate the relationship
between BrCa beliefs and FPM status, and personality traits and coping behaviors would
function as moderators of this relationship. We did not uncover any mediators, but the
employment of collective coping strategies were found to decrease the perception of
mammography barriers.
Collective coping as measured by the ACSI is similar to the social support
subscales of other assessments such as the Brief COPE, but the ACSI subscale contains
activities that are prevalent in collective cultures and specific to the Black American
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experience.30,48,51 The positive effect of this coping style appears to indicate that
collective coping strategies are protective for individuals in more collective cultures.
Molina et al. found differences in coping behaviors and negative psychosocial outcomes
between White and Latina women, but the impact of collective coping strategies on
psychosocial outcomes was not reported due to inadequate reliability of the Brief COPE’s
social support subscale.31 Another analysis conducted by the same authors revealed
negative psychosocial outcomes among Latina women with FPM results who did not
discuss their results with their family or friends.52 Together, these findings demonstrate
the need for investigations of the effect coping behaviors on BrCa screening outcomes
among women of color with FPM results.
Lastly, we postulated that the impact of FPM status on BrCa behavioral beliefs
would lead to lower mammography intention among the women surveyed. This
hypothesis was only supported for the perception of barriers to mammography. In this
sample, high levels of perceived mammography barriers were associated with the receipt
of FPM results and decreased intentions to complete mammography screening and
follow-up testing. In DeFrank et al.'s study, FPM status was connected with the delayed
completion (longer than two years) of participants' next screening mammography, and
mammography delay was mediated by provider recommendation.16 Women with FPM
results were more likely to experience mammography delays if they did not receive a
mammography recommendation.16
It will be important to examine whether provider recommendation has similar
impact on subsequent mammography behavior among Black women with FPM results,
especially as primary care providers are less likely to discuss mammography screening
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recommendations with their Black patients.53,54 In this sample, respondents were asked
the reason for their most recent screening mammogram using a multi-select survey item.
Twenty-six percent of respondents indicated scheduling their index mammogram due to a
recommendation from their provider (there were no differences in cases and controls).
Most respondents (82.7%) reported scheduling screening mammograms “because it was
time”. This finding appears to confirm the lack of provider discussion about
mammography reported in other studies.53,54
Limitations. The following limitations should be noted when considering the
study’s findings. Psychosocial measures were collected retrospectively, thus were subject
to recall bias. As both groups were subject to recall bias, we believe the impact on our
findings is minimal. It is possible that there were small differences in BrCa screening
beliefs that could not be detected due to the relatively small sample size. This study
examined BrCa screening and follow-up intentions, not actual behavior. Cross-sectional
sampling used for analysis makes this study exploratory, but provided information that
can guide longitudinal studies of FPM outcomes among Black women.55
Additionally, the long-term effect of receiving an FPM result are unclear as
respondents were assessed between 6 and 12 months after their index mammogram
(mean response time was 199 days). Respondents were asked if they had a FPM before
their most recent mammogram and 24% of controls reported a previous FPM result.
Sensitivity analyses were run with respondents who ever had a FPM serving as cases and
those never receiving a FPM result as controls. Similar trends emerged from this analysis,
but many did not achieve statistical significance. These results suggested that effects of a
FPM result are time-dependent. This study has many features that strengthen its findings,
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specifically the use of: a case-control design, culturally appropriate standardized
measures, clinical records to validate FPM status, and a theoretically grounded
conceptual model to guide measure selection and data analysis.
Conclusions
Influences on BRCA screening beliefs and mammography intentions vary as
result of the different social and cultural contexts that shape their healthcare experiences.
Black women exist in an environment with lower levels of BrCa knowledge, fewer
discussions with healthcare providers about BrCa screening, and high rates of BrCa
mortality, thus the use of collective coping strategies improves Black women’s response
to the potentially negative experience of receiving FPM results.1,8 Our findings highlight
the importance of conducting culturally specific research with groups that experience
racial inequalities, as behavioral pathways and solutions may vary by racial/ethnic group.
Additional research examining the influence of Black women’s previous BrCa screening
encounters and responses to those encounters is needed to better understand behavioral
factors linked to mammography delay.
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Table 4.6 Demographic, Screening, and Psychosocial Characteristics of Black
Women Completing Screening Mammography by Outcome n =117*
Cases
(False Positives) n= 54

f

Percentage (%) or
Mean (Std)

Age Range
40-49
14
50-64
25
65+
15
Education
High school or less
34
College or more
20
Health Insurance Type
Private
26
Public
27
Uninsured
1
Geographic Location
Urban
52
Family History of Breast Cancer 16
Yes
Age at First Mammogram
Less than 30 years old
7
30-39 years old
26
40-49 years old
15
50 years or older
4
Perceived Susceptibility
43
(Range: 4-15)
Perceived Benefits (Range: 10-16)
52
Perceived Barriers (Range: 10-26)
50
Intention – Screening
Mammography
Very Likely
50
Likely
3
Unlikely
1
Very Unlikely
0
Intention – Mammography Follow
Up
Very Likely
49
Likely
4
Unlikely
0
Very Unlikely
1
Trait Anxiety (Range: 10-32)
46
State Anxiety (Range: 10-34)
49
Breast Cancer Specific Anxiety
53
(Range: 0-18)
Depression (Range: 0-22)
44
Coping Style
Cognitive/Emotional (Range: 0-31)
45
Collective (Range: 0-21)
50
Spiritual (Range: 0-27)
46
Ritual (Range: 0-9)
53
*Bolded values are statistically significant (p<0.05)
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Controls
(Normal Mammograms)
n=63
Percentage (%) or
f
Mean (Std)

25.9
46.3
27.8

8
38
17

12.7
60.3
27.0

63.0
37.0

49
14

77.8
22.2

48.2
50.0
1.8

27
33
3

42.9
52.4
4.7

96.3
29.7

62
19

98.4
30.2

13.5
50.0
28.9
7.6
7.2 (2.7)

7
23
25
6
55

11.5
37.7
41.0
9.8
7.3 (2.7)

14.5 (1.8)
13.8 (4.7)

61
57

14.4 (1.8)
12.2 (3.2)

92.6
5.6
1.8
0.0

59
3
0
1

93.7
4.8
0.0
1.5

90.7
7.4
0.0
1.9
17.4 (5.1)
19.4 (4.9)
4.3 (4.7)

57
4
0
1
52
56
57

91.9
6.5
0.0
1.6
17.2 (5.3)
16.4 (4.8)
2.2 (3.5)

6.0 (5.8)

56

3.9 (4.9)

13.0 (8.9)
6.0 (5.2)
14.2 (7.6)
0.7 (1.5)

54
54
54
57

9.3 (8.8)
6.1 (5.9)
12.5 (8.2)
0.9 (1.9)

Table 4.7 Multiple Regression Models Describing Influences on Breast Cancer
Screening Beliefs*
Model R2
Independent Variables

Perceived
Susceptibility
0.22

Mean (SE)
Case
6.5 (0.6)
(FPM Result)
Control
6.8 (0.6)
Age Range
40-49
5.6 (0.8)
50-64
7.0 (0.6)
65+
7.4 (0.8)
Education:
High school or
6.4 (0.6)
less
College or more
6.9 (0.6)
Health Insurance:
Private
7.8 (0.4)
Public
7.1 (0.4)
Uninsured
5.0 (1.5)
Family History of Breast Cancer
Yes
7.2 (0.7)
No
6.1 (0.6)
Breast Cancer Specific Anxiety
6.6 (0.6)
(Centered at Mean)
Age at First Mammogram:
< 30 years old
> 30 years old
*Bolded values are statistically significant at the p<0.05 level.

104

Perceived Benefits
0.09

Perceived
Barriers
0.21

Mean (SE)
14.8 (0.4)

Mean (SE)
13.4 (0.9)

14.5 (0.4)

11.4 (0.9)

14.4 (0.5)
14.8 (0.4)
14.7 (0.5)

11.6 (1.1)
13.1 (0.8)
12.5 (1.1)

14.5 (0.4)

13.2 (0.9)

14.8 (0.5)

11.6 (1.0)

14.3 (0.3)
14.4 (0.3)
15.2 (1.1)

10.5 (0.7)
11.8 (0.8)
14.9 (2.0)

14.5 (0.5)
14.8 (0.4)
14.6 (0.4)

10.9 (1.2)
13.9 (0.8)

Table 4.8 Multiple Regression Models Describing Influences on Breast Cancer Screening Intentions
Model R2
Independent Variables

Mammography Screening
Intentiona
0.09
0.21
Mean (SE)
3.8 (0.1)

Mean (SE)
3.8 (0.1)

Mammography FollowUp
Intentiona
0.10
0.31
Mean (SE)
3.7 (0.1)

Mean (SE)
3.8 (0.1)
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Case
(FPM Result)
Control
3.9 (0.1)
3.8 (0.1)
3.9 (0.1)
3.8 (0.1)
Age Range
40-49
3.8 (0.1)
3.8 (0.1)
3.9 (0.1)
3.8 (0.1)
50-64
3.8 (0.1)
3.8 (0.1)
3.9 (0.1)
3.8 (0.0)
65+
3.8 (0.1)
3.8 (0.1)
3.7 (0.1)
3.8 (0.1)
Education:
High school or
3.8 (0.1)
3.8 (0.1)
3.8 (0.1)
3.8 (0.1)
less
College or more
3.9 (0.1)
3.8 (0.1)
3.8 (0.1)
3.8 (0.1)
Health Insurance:
Private
4.0 (0.1)
4.0 (0.1)
3.9 (0.1)
4.0 (0.0)
Public
3.9 (0.1)
3.9 (0.1)
3.9 (0.1)
4.0 (0.0)
Uninsured
3.6 (0.2)
3.6 (0.1)
3.6 (0.2)
3.6 (0.1)
Family History of Breast Cancer
Yes
3.8 (0.1)
3.8 (0.1)
No
3.8 (0.1)
3.8 (0.1)
Breast Cancer Specific Anxiety (Centered at Mean)
3.8 (0.1)
3.8 (0.1)
Age at First Mammogram:
Less than 30 years old
3.8 (0.1)
3.8 (0.0)
More than 30 years old
3.8 (0.1)
4.0 (0.0)
Perceived Susceptibility (Centered at Mean)
3.8 (0.1)
3.8 (0.1)
Perceived Barriers (Centered at Mean)
3.8 (0.0)
3.8 (0.0)
*Bolded values are statistically significant (p<0.05) a=Single item measure with 1= Very Unlikely and 4 = Very Likely

Percieve Barriers to Mammography Score

Figure 4.1. Black Women’s’ Perception of Mammography Barriers by Screening Results
Stratified by Coping Strategy Usage
Perception of
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CHAPTER 5.
SUMMARY, IMPLICATIONS, AND RECOMMENDATIONS
This chapter contains an integrated summary of the results presented in Chapter 4.
A discussion of the results, study limitations, conclusions, and implications for public
health practice and cancer inequities research is presented. Future research directions
generated from this work will also be presented.
5.1 Summary of Findings
This purpose of this dissertation research was to determine the impact of
multilevel factors on the processes and outcomes associated with FPM results in Black
women. The study had two specific aims.
Specific Aim 1: To describe, using a mixed methods approach, the organizational
and provider-level characteristics of mammography facilities and their impact on Black
women’s FPM experiences and outcomes.
Research Question 1.1. What organizational, provider, and patient-level
characteristics predict high levels of satisfaction with their clinical encounter among
Black women experiencing a FPM result?
Of the six domains of satisfaction examined, general satisfaction and satisfaction
with provider’s interpersonal style were not influenced by any of the characteristics
included in this analysis. Satisfaction with the convenience of mammography was
inversely related to patient factors, such as having a FPM result, experiencing
discrimination during the screening encounter, and having a family history of BrCa. The
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negative influence of FPM status and experiencing discrimination on satisfaction with
convenience mirror the findings of previous studies of this relationship.158,178,194,222,263
Meanwhile, less data were available to describe the relationship between family history
and satisfaction with mammography convenience.
Even though FPM rates were higher among women with a family history of
BrCa45, the proportion of women in this sample who had ever had a FPM result was not
significantly different for women with and without a family history of BrCa (62.8% vs
57.3%, p = 0.68). It is possible that some other aspect of the screening experience,
potentially additional testing not related to abnormal mammography results, may impact
satisfaction for this subgroup of Black women. Yet, it is not entirely clear what
mechanism is responsible for the decreased satisfaction among this subpopulation of
Black women as so few studies of family history have included Black women or
mentioned the race of study participants.282–284
Satisfaction with provider’s communication of information was solely influenced
by FPM status. Women with FPM results were less likely to be satisfied with the
information they received during their clinical encounters. Inadequate communication
concerning abnormal screening results has been a recurrent theme in studies of BrCa
screening follow-up in Black women.89,154,194,263,269
Both satisfaction with provider competence and the physical environment were
associated with facility and provider-related characteristics. In particular, the presence of
educational materials increased women’s satisfaction with provider’s expertise and the
clinical environment. Previous work on satisfaction with the mammography process, in
general, has looked only at a few aspects of the facility environment not related to
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communication, such as waiting times or ease of scheduling. 158,178,260 We found that
higher levels of dissatisfaction were associated with an older patient population, more
screening hours, and increased levels of providers’ concern with patients’ physical
discomfort. It is possible that the age of the patient population and a greater number of
screening hours may increase women’s perception of longer waiting times. Providers’
concern about physical discomfort may have served to make them timid and/or less
confident with patients during the clinical encounter.
Specific Aim 2: To determine, through quantitative methods, the relationship
between receiving a FPM result and future mammography intention among Black
women.
Research Question 2.1. What is the relationship between receiving a FPM result
and BrCa behavioral beliefs (perceived benefits of mammography, perceived BrCa
susceptibility, and perceived barriers to mammography screening) among Black women?
Of the three BrCa screening beliefs measured, FPM only had a direct influence on
the perception of barriers to mammography screening. The lack of relationship between
perceived BrCa susceptibility and FPM status fits with several previous analyses of these
variables.43,151,163,168 Other studies examining the connection between the perceived
benefits of mammography and FPM status also failed to find a significant
association.177,178
Another explanation for null results as it relates to the relationships between FPM
status, perceived susceptibility to BrCa, and benefits of mammography may be the timing
of the assessment. Given that women were asked to recall their state of mind for an event
which occurred 6 months prior, it is possible that women’s memories are influenced by
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their final results. It is equally likely that topics such as barriers to screening may be more
salient and easier to recall compared to concepts such as susceptibility to BrCa or the
benefits of screening.
Women with recent FPM results displayed a higher perception of screening
barriers. These results are in direct contrast to DeFrank et al. (2012) who reported no
association between FPM status and perceived barriers score.43 Differences in these
findings may be attributed to differences in measurement of perceived barriers. DeFrank
et al. (2012) used unstandardized items that only assessed financial barriers as opposed to
the current study which assessed financial, logistical, and psychosocial barriers using a
shortened version of the barrier subscale of the Champion Attitudes Towards
Mammography and Breast Cancer Scale.43,258 It is likely that the barriers assessed by the
Champion Attitudes Towards Mammography and Breast Cancer Scale are more
representative of the varied outcomes associated with the receipt of FPM and allowing
for the detection of the relationship between these two variables.37,38,258
Research Question 2.1.a. Do Black women’s emotional states explain the
relationship between a FPM result and BrCa behavioral beliefs (perceived benefits of
mammography, perceived BrCa susceptibility, and perceived barriers to mammography
screening)?
Levels of general anxiety, BrCa-specific anxiety, and depression were assessed
and tested as mediators of the relationship between perceived barriers and FPM status.
Trait anxiety appeared to function as mediator in preliminary tests; thus it was included in
mediation analyses. None of these factors explained the relationship between this BrCa
screening belief and mammography outcome. The transactional model of stress and
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coping conceptualizes that individuals will generate multiple appraisals in response to
stressful events.200,201 Primary appraisals lead to emotional responses while secondary
appraisals lead to coping behaviors and/or changes in beliefs. Emotions are theorized to
accompany appraisals and not influence appraisals. The independent nature of the
primary and secondary appraisals and different states affected would explain the lack of
relationship between emotional states and BrCa screening beliefs.201
Research Question 2.1.b. Does the relationship between receipt of FPM results
and BrCa behavioral beliefs (perceived benefits of mammography, perceived BrCa
susceptibility, and perceived barriers to mammography screening) vary by coping
strategy employed?
Several coping styles were tested to determine if they had any influence on the
relationship between perceived barriers to mammography and FPM status. Of the
different coping styles measured (cognitive/emotion debriefing, collective, spiritualcentered, and ritual-centered), collective coping was found to decrease the detrimental
influence of FPM results on the perception of barriers to mammography. Black American
culture is highly collective due to its origins in African culture and the need to engage in
collective behavior to survive various forms of racial oppression and disenfrachisement.
These findings along with other studies illustrate how the collective aspects of Black
culture can serve as resources that Black women can access to improve their
health.63,237,238 Previous research on coping behaviors in response to a FPM result
examined the relationship between coping behaviors and emotional states/distress, as
opposed to BrCa beliefs.157,180 In the current sample, none of the coping strategies
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measured were found to alter the relationship between FPM status and anxiety (general
nor BrCa-specific).
Research Question 2.2. What is the relationship between BrCa behavioral beliefs
(perceived benefits of mammography, perceived BrCa susceptibility, and perceived
barriers to mammography screening) and intention to complete future mammography
screening?
To establish the potential link between FPM and mammography intention in this
small sample, models linking BrCa screening beliefs and mammography intention were
created. Mammography intention was found only to be influenced by the perception of
barriers to mammography. It is not surprising that the perceived benefits of
mammography and the perceived BrCa susceptibility were not related to mammography
intention in this sample. Reviews of the health belief model constructs failed to find a
relationship between perceived benefits and mammography screening behavior.189,285
Despite evidence that perceived susceptibility increases mammography screening
behavior among White women, this relationship has not been detected among samples of
Black women.189,190,274 Perceived barriers to mammography has been consistently
associated with lower levels of mammography intention and screening, and the current
study replicates these findings.189,285
In summary, multilevel factors were proven to influence the BrCa screening
experiences of Black women with FPM. Organizational and provider level characteristics
had positive and negative effects on Black women’s satisfaction with BrCa screening
services in general. FPM status was related to lower levels of satisfaction and increased
perceptions of the barriers to completing BrCa screening services. Literature indicates
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that mammography satisfaction facilitates and the perception of barriers to
mammography inhibit mammography behaviors.189,260–262,285 The findings of this
dissertation research point to a link between FPM status and mammography behaviors
through perceptions of the screening experience and subsequent influences on BrCa
screening beliefs.
5.2 Strengths and Limitations
Conclusions drawn from the research findings are strengthened by several
features of the study. This research includes a dedicated examination of influences in
mammography satisfaction among Black women which is an important, but understudied
topic. As a result, valuable information about the characteristics of the clinical encounter
related to satisfaction for Black women may be used to guide future work on this topic.
Additionally, the use of mixed-methods to collect information about features of the
physical and social environment of healthcare facilities represents a more comprehensive
approach to describing how the clinical environment influences patient experiences
compared to quantitative-only or qualitative-only studies. Another asset of this research
relates to the designs employed to address both specific aims. Linking characteristics at
the organization, provider, and patient levels to women’s experiences at a single
screening episode is a novel feature of this work as many studies of mammography
screening only examine influences at one or two levels at most. Applying a case-control
design to the investigation of the relationship between FPM status and BrCa screening
beliefs and intentions enhances the internal validity of the results as does the use of
culturally appropriate measures of BrCa screening beliefs and coping behaviors. The use
of clinical measures to validate self-reported screening data also strengthens our
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conclusions. Lastly, the use of a theoretically and empirically grounded conceptual model
enhanced the selection of appropriate variables and analytic methods to understand how
FPM results affect Black women.
There were several limitations of this work that may impact the interpretation of
the results. First is the small sample size. This issue prevented the inclusion of
organizational, provider, and patient-level factors in one model for each type of
mammography satisfaction. Another challenge associated with small sample size was the
inability to collect data from all healthcare providers with patient contact. These
limitations make the analyses of influences on mammography satisfaction, BrCa
screening beliefs, and mammography intention exploratory in nature. However, these
analyses can support the identification of variables to be incorporated in future studies of
mammography beliefs and behaviors.
Secondly, data for this study came from a single health system reducing the
external validity of the results. Time and financial constraints would not allow for the
inclusion of multiple hospital systems to generate a representative sample. A feature of
this study linked to the focus on a single hospital system is the opportunity to examine the
impact of standardized notification procedures on mammography satisfaction. This
characteristic of the system limited our ability to determine how specific communication
methods/protocols may impact satisfaction. Yet, the focus on a single system also proved
to be a strength of the study as it allowed for the explanation of the lack of site-level
differences in mammography satisfaction despite the variation in all of the other
characteristics of the participating sites.
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Third, the provider and patient surveys did not measure all variables that may
influence women’s FPM experiences. In the case of the provider survey, factors, such as
the volume of images read or the double reading of images, were not assessed. These
factors are only relevant for radiologists, which represent 12.5% of the provider survey
respondents. Few studies examined how non-physician staff involved in mammography
procedures impacted women’s clinical encounters and this study provided important
information as to how non-physician staff shaped women’s experiences.
Medical conditions/issues, such as pain during the mammography procedure,
mental health diagnoses, and chronic conditions that limit mobility or ability to complete
mammography screening and follow-up procedures, were not assessed as part of the
patient survey. Other cancer-related beliefs such as fatalism and medical mistrust have
been shown to be salient influences in this population, but they were not included in the
patient survey. These factors may impact women’s experiences and intention to complete
screening; however there is no reason to believe that these factors would vary
considerably between cases and controls. Psychosocial outcomes, including worry, fear,
and distress, were associated with FPM status in other studies, but these variables were
not measured in this study to minimize respondent burden.
Fourth, the primary endpoint of the analyses examining individual FPM outcomes
was mammography intention and not behavior (i.e. repeat mammography). Studies are
inconsistent as to the links between mammography intention and actual mammography
behaviors.189,285 Given that recommended mammography screening intervals range from
one to two years; it was not feasible to collect prospective screening data for this study.
The assessment of perceived barriers to mammography, the BrCa screening belief most
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consistently associated with mammography behavior, did strengthen the assertion of a
link between FPM status and future mammography behavior.
Lastly, the fact that patient survey respondents were asked to retrospectively
recall emotions and mammography experiences has to potential to weaken the study
findings. Participants were surveyed six months after the initial screening mammogram to
allow for the verification of final screening results. On average, diagnostic results were
verified in this sample within three months, and future studies should consider a shorter
follow-up time to reduce the potential for recall bias. Yet, the case-control design of this
study was designed to yield two groups that were similarly affected by recall bias as well
as social desirability to indicate intentions to complete future BrCa screening.
5.3 Conclusions
The goal of this study was to examine how multilevel factors, characteristics of
the organizations, healthcare providers, and patients involved in the mammography
screening process influence Black women’s responses to receiving a FPM result. While
no factors were associated with patients’ general satisfaction and satisfaction with
provider’s interpersonal style, organizational level factors related to the patient
population, services offered, and the physical environment had an impact on patients’
satisfaction with provider’s skills and physical environment of the mammography
facility. Provider perceptions of patients’ comfort were associated with patients’
satisfaction with providers’ skills. Patient characteristics related to past and current
screening experiences including a family history of BrCa, experiencing discrimination
during the most recent screening experience, and receiving a FPM result negatively

116

impacted mammography satisfaction. These same characteristics had similar negative
effects on BrCa screening beliefs and attitudes.
FPM status was associated with increased levels of general and breast cancer
anxiety, but subsequently these emotional states did not influence BrCa screening beliefs.
Receipt of FPM results did have adverse effects on women’s intention to complete
mammography screening and follow-up procedures through an increased perception of
the barriers to mammography completion. Culturally-specific behavior in the form of
collective coping strategies weakened the effect of perceived barriers on screening
intention. Together, these findings point to the potential role of past screening
experiences on future screening behavior through influences on BrCa screening beliefs
and intention. Additionally, these results also underscore the value and necessity of
understanding the contextual influences of the group whose health outcomes are being
investigated. Knowledge of the historical, social, and cultural factors that surround the
health behaviors of groups, such as Black women, can inform the measurement of
culturally-appropriate experiences and behaviors and the development of culturallyrelevant health behavior theories. This research has important implications for clinical
practice and public health research as a whole, and with specific ramifications for those
engaging in activities designed to reduce racial inequities in BrCa burden.
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5.4 Implications and Recommendations
5.4.1

Clinical Care
Insights generated from this research suggest several strategies that can be

employed to improve the screening and follow-up process for Black women. One
important result of this research is the lack of facility-level differences in mammography
satisfaction, which may be attributed to the standardization of notification procedures
across facilities. Despite differences in patient populations, services, and clinical
environments, women requiring additional testing are contacted via telephone after their
initial mammogram is read (often within 24 hours) and by postal mail (regardless of
phone contact) at all facilities. Analyses did reveal that providers’ communication about
screening and perceptions of patients had an impact on Black women’s satisfaction with
the encounter. It would stand to reason that the standardization of notification procedures
may be one strategy that can improve Black women’s satisfaction with the
mammography encounter.
The development and testing of standardized scripts to guide provider
interactions, particularly around follow-up testing may improve satisfaction with the
clinical encounter. As part of these scripts, providers can also encourage Black women
with FPM results to speak to their family and friends about their screening results to
reduce their perception of the challenges of completing follow up-testing. Additionally,
study results indicated that the presence of materials with information about the screening
process had a positive impact on Black women’s screening and follow-up experiences.
Making standard patient education materials from Susan G. Komen or the American
Cancer Society available in the waiting room and/or including these materials with postal
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notifications of abnormal results can address some of the communication issues
commonly reported by this population.
Lastly, Black women with FPM results reported less satisfaction with the
convenience of mammography and were more aware of the barriers to completing
screening. Survey items measuring satisfaction with convenience described logistical
challenges related to the time needed for, distance to, and validity of follow up visits. The
aforementioned factors can impact whether a woman is able to return for follow-up or the
length of time it takes to achieve diagnostic resolution. Changes in the scheduling of
screening can reduce some of the negative effects of FPM. Instead of scheduling all
women for screening mammograms in time slots reserved for general screening, women
who are likely to have FPM results could be given the option of complete screening
during diagnostic screening slots.
In the participating hospital system, mammography facilities held blocks of time
specifically for women who need to return for follow up procedures. Women are
informed that their visit will take longer, because the radiologist performing the
procedure will read the images while the woman is waiting. If necessary, the radiologist
will perform additional procedures so that the woman can receive a final result in person,
unless a biopsy is required. If a woman completes a biopsy as part of her follow up
procedures, a pathologist needs to process the tissue sample and prepare a final report. A
nurse is scheduled to call the woman and inform her of the pathology results within 24
hours of the biopsy. Women who are likely to have a FPM result could be offered the
option of proceeding with their screening as it if was a follow-up visit and schedule their
visit during one of the diagnostic testing slots. Providing women with this option has the
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potential to address the logistical barriers in addition to communication issues related to
follow-up testing. Providing educational materials about mammography follow-up to
women suspected of FPM results while waiting for screening and diagnostic testing can
reduce fears and other negative psychological outcomes.
Although it is not possible to predict which women will have abnormal screening
mammograms, there are several characteristics that increase the likelihood of receiving a
FPM result. Women with dense breasts (BI-RADS Breast Density rating of 3 or 4), who
are completing their first mammogram, and those with previous FPM results can be
identified and offered the choice of completing initial screening during periods reserved
for diagnostic follow-up periods. Women with increased risks of FPM who complete
mammography during these slots would be asked to stay longer so that their initial
mammograms can be read on site. These women would complete diagnostic testing on
site if necessary.
5.3.1

Population Level Mammography Screening Behavior
In fall 2015, a few months before the start of data collection for this study, the

American Cancer Society changed its mammography screening guidelines and
recommended that average risk women began screening at age 45 and continue screening
annually until age 54.51 After age 55, women can choose to screen annually or
biennially.51 These guidelines differ from the American Cancer Society’s previous
guidelines recommending annual mammography for women starting at age 40, and the
United States Preventive Services Task Force’s more controversial guidelines
recommending biennial mammograms for women between the ages of 50 and 74.286,287
Negative consequences of FPM results, including additional financial costs and negative
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psychosocial outcomes, were an integral factor in recent decisions to increase the age of
screening initiation and lengthen screening intervals.51,287,288 In the case of Black women,
these changes have been criticized as the evidence that informed these changes utilized
samples (actual and simulated) of White women, thus the evidence did not account for
racial differences in the age at BrCa diagnosis, BrCa tumor severity, incidence, or
mortality.289 Additionally, the research forming the basis of these recommendations does
not consider the lack of research on FPM outcomes in Black women. As a result, the
current study is one of the few that can take up the discussion of the impact of FPM in
Black women and the potential implications on population-level screening behaviors for
this group. Several studies indicate that Black women continue to commence annual
mammography screening at age 40, meaning that FPM rates are unlikely to change for
this group.253,280,290–292 Some researchers speculate that the persistence of screening
behavior may be a result of women and/or their provider’s lack of knowledge around or
skepticism towards the new screening guidelines.263,280,292 Published data and findings
from the current study revealed low rates of provider recommendation for mammography
among Black women. These findings appear to support the idea that Black women are
skeptical of or unaware of the guideline changes and provide more evidence as to the
different healthcare contexts that surround Black women’s healthcare experiences.263
Overall, trends in Black women’s mammography screening behaviors underscore the
need to develop strategies to mitigate the potentially negative influences of FPM results
on Black women’s BrCa screening beliefs and behaviors.
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5.3.2

Theory Development and Application in Health Equity Research
Considering the results of this study, future research on the influences on

mammography follow-up in Black women should seek to integrate health behavior
theories and theories guiding the organization and processes associated with clinical
services. Much of the FPM literature focuses on the influence of clinical processes on
outcomes without adequate consideration of the factors that drive the adoption of
screening behaviors. Specifically, more work needs to be done to find and develop
theories that accurately predict mammography behavior in different racial and ethnic
groups. Popular health behaviors theories such as the health belief model or the theory of
reasoned action and planned behavior have not been consistently related to
mammography behaviors across various racial and ethnic groups.189,274,285 Even
considering the theoretical constructs that consistently influence mammography
screening outcomes, various operationalizations of these constructs exist, but the vast
majority of scales have not been developed with women of color. This study used a
culturally-relevant version of health belief model constructs and detected statistically
significant relationships between one BrCa belief and mammography intention. Research
needs to be conducted to develop reliable and valid measures that conceptualize
behavioral constructs in different racial/ethnic groups.
The transactional model of stress and coping has important applications to cancer
prevention and health inequities research and should be explored in future studies. Much
of the research on FPM focuses on psychosocial outcomes such as emotions in response
to a stressful event, but the transactional model of stress and coping describes emotional
responses occurring in a separate pathway from behaviors and/or changes in beliefs.200
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Using the model to classify health-related events and potential responses to these events
may improve researchers’ ability to understand and incorporate the impact of past
experiences on an individual’s current cancer prevention beliefs and behaviors. In
combination, the use of the previously mentioned theories and models would have the
potential to enhance research and interventions devoted to improving the uptake of cancer
screening behaviors across racial and ethnic groups.
Lastly, theories and models used in health inequities research would benefit from
explicitly focusing on the role of deep cultural factors such as social roles, norms, and
behavior and the intersection of cultural factors with characteristics like gender, sexual
orientation, and geography (rurality, region). A focus on deep cultural factors requires
time spent considering how culture influences behavior along various intersections and
how to assess these influences. Increased development and use of culturally-relevant
measures of behaviors, beliefs, and attitudes is needed to discern culturally-specific
nuances that shape health behaviors in different racial and ethnic groups.
5.3.3

Assessment and Application of Multilevel Influences in Health Equity
Research
The socioecological model describes how characteristics at multiple levels

(intrapersonal, interpersonal, community, organizational, and policy) influence health
behavior, with abnormal mammography results serving as the perfect demonstration of
how these levels converge for one health behavior (achieving diagnostic resolution).221,244
Given the role of federal and state level health policy, institutional policies and practices,
and physical and social aspects of the environment in creating and maintaining racially
driven health inequities, multilevel interventions are needed to enhance health
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equity.293,294 As part of this study, multilevel influences on mammography satisfaction
were investigated and many of the challenges associated with multilevel analysis were
highlighted in the process. While influences on satisfaction were detected at each of the
three levels measured, stable multilevel models could not be created due to the small
sample size of patient participants. Sample size was also challenge at the site level as
there were only five mammography facilities. The small sample size and limited
procedures available to compensate for the lack of variety in the sample prevented a
comprehensive analysis of the relative contributions of each level to the behavior studied
and/or interactions between levels.293 Despite the primarily descriptive nature of the
analyses conducted, multilevel influences were operationalized and measured in this
study. These processes and findings can be used to guide future efforts to examine
screening behaviors in different groups using more advanced methods and larger
samples.
5.4 Future Research Directions
Additional data were collected as part of this study, but were not included in the
specific aims of this study given the small sample size and the desire to not to overfit
regression models. Future research on this topic will take the form of: 1) Secondary
analyses of dissertation data and 2) New studies building on the findings of this
investigation. Additional analyses include investigations of the relationship between
mammography satisfaction and intention. Mammography satisfaction is an understudied
topic, but very few studies attempt to link women’s satisfaction in the mammography
encounter with their intention to complete future mammography behavior. Of the existing
research, few have been conducted with Black women. Items from the patient survey will
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be used to develop models examining the relationship between various domains of
mammography satisfaction and mammography intention in Black women. The
explanatory power of culturally relevant influences such as experiencing discrimination
during the clinical encounter will also be explored in this analysis.
As a result of the changes in mammography screening guidelines and new
research reporting that Black women receive fewer provider recommendations for
mammography, items assessing awareness of changes in mammography screening
guidelines, and participation in conversations with primary care providers regarding
mammography screening intervals were included in the patient survey. Self-reported
screening histories were verified with medical records and that information in
combination, with the knowledge, awareness, and conversation variables will be used to
determine what (if any) mammography screening guidelines were followed by patient
participants.
Breast density is another important factor that may influence Black women’s BrCa
screening behavior, but very few studies examine Black women’s knowledge of their
own breast density, and/or their understanding as to how breast density impacts their
BrCa risk. Even less research is devoted to understanding how mammography providers
describe breast density. Open-ended items from the patient and provider surveys will be
used to explore patients’ perceptions of and reactions to having dense breasts and the
ways that providers communicate with women about this issue.
As previously mentioned, mammography screening behavior can be influenced by
factors at multiple levels. Community or neighborhood is another factor that has been
shown to impact mammography screening behaviors. Screening data used to classify
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facilities will be merged with spatial variables to measure the impact of neighborhood
and individual characteristics on mammography follow-up times.
New studies will focus on the role of coping behaviors on mammography
screening beliefs and behaviors in a racially diverse group of women with FPM results.
Data from this and other studies suggest that coping and BrCa screening beliefs are
grounded in cultural factors, and their impact on BrCa screening intention may vary by
racial/ethnic group. A study is planned to collect qualitative data to explore experiences
with and responses to the receipt of FPM results among Black women, White women,
and Latinas in rural North Carolina. The analysis of the influence of coping behaviors on
BrCa screening beliefs is novel and has the potential to impact the development of
intervention strategies to change BrCa screening beliefs and mammography behaviors in
women facing increased BrCa mortality such as those in rural North Carolina.
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